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Summary
The work presented in this thesis is a study of the role of gC in adsorption of herpes 
simplex virus type 1 (HSV-1).
This study used several strains of wild type HSV-1 and their gC negative mutants 
strains 17, F, SC 16 and HFEM. In contrast to published results, comparison of the 
particle to p.f.u ratios of each wild type strain to their gC negative form showed similar 
values, differing by two fold at most (Herold et al, 1991).
Initially the ability of radioactively labelled strain 17 wild type and gC negative mutant 
virions to bind to BHK21/C13 and C6 gliomal cells was examined. There was no 
difference between either virus or between cell lines.
Subsequently the adsorption kinetics of HSV-1 strain 17 wild type virus and its gC 
negative mutant were studied on BHK21/C13 cells. Again no differences were 
observed.
Similarly a study of the rate of penetration of the HSV-1 strain 17 wild type and gC 
negative viruses demonstrated no difference in the rate of penetration into BHK21/C13 
cells.
The adsorption characteristics of the different strains and their gC negative mutants used 
in this study were compared on BHK21/C13 cells, with no difference being seen 
between any parental strains, and its gC negative mutant or between HSV-1 strain 17 
wild type and any other.
The adsorption kinetics of all strains and their gC negative mutants were compared on 
Vero cells with no difference being seen.
p-Galactosidase staining of lac Z expressing forms of some of the viral strains (HSV-1
/
strain 17, its gC negative mutant, SC16-AUL44-Z and HFEM-AUL44-Z) was used to
examine adsorption kinetics on HeLa and 3T6 cells. All viruses displayed similar 
adsorption kinetics. ,.r * - -
In heparin inhibition assays all viruses demonstrated the same pattern of blocking by 
exogenous heparin although the levels of inhibition differed between strains. 
Experiments to determine the intracranial pathogenicity revealed no significant 
difference in pathogenicity with LD50 values of <101 and 5x10’ for the wild type and 
mutant respectively.
In peripheral pathogenicity and latency studies of the HSV-1 strain 17 viruses a ten fold 
difference was observed between the wild type and the mutant virus in LD50 data; this is 
not a significant difference. Reactivation frequency was also shown to be similar.
The use of Southern and Western blotting confirmed the structure and gC expression of 
the HSV-1 strains and their mutants.
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Chapter 1: Introduction
1. Introduction.
1.1
The herpesviruses.
1 .1 .1
General properties
Herpes simplex virus (HSV) is a member of the herpesviridae family which includes a large 
number of medically and veterinarily important viruses. They produce a variety of diseases 
in humans and are widespread in other vertebrates (Minson, 1989). There are more than 
eighty members of this family (Nahmais et al., 1972) which are all morphologically similar 
(Fenner, 1976). The virion (120-200 nm in diameter) consists of four structural components: 
(a) a core made up of a linear double-stranded DNA molecule of 120-240 kbp; (b) an 
icosohedral capsid 100-125 nm in diameter composed of 162 capsomeres; (c) an amorphous 
layer termed the tegument which surrounds the capsid - this is often distributed 
asymmetrically and may be variable in amount; (d) the envelope, a bilayered lipid containing 
membrane which surrounds the tegument and has surface projections consisting of virus 
encoded glycoproteins (Wildy et al, 1960; Roizman and Furlong, 1974). The herpesviruses 
encode around forty 'core' genes which show amino acid sequence homology between all of 
the herpesviruses and are thought to result from a common evolutionary progenitor (Davison, 
1993). These core genes encode structural proteins and proteins involved in virion 
morphogenesis, nucleotide metabolism and DNA packaging.
All members of the family possess a linear double stranded genome (Roizman, 1982). 
However, herpesviridae family members are readily distinguished using criteria such as base 
composition, genome structure, immunological cross-reactivity, biological properties, size 
and DNA sequence.
1 . 1.2
Classification.
Based on their biology, the Herpesviridiae family can be sub-divided into three groups, the 
Alpha, Beta and Gammaherpesviriniae (Roizman, 1982). The distinction between the Alpha 
and Gamma subfamilies is based on host range and in vitro characteristics, while the 
differentiation between the Beta subfamily and the others is based primarily on the length of 
the reproductive cycle and slow development of cytopathology in tissue culture.
1
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The Alphaherpesviriniae are neurotropic and frequently, but not exclusively, become latent in 
neurones of the dorsal root ganglia (DRG) of the peripheral nervous system (PNS). They are 
characterised by their short reproductive cycle and rapid spread of infection in cell culture 
resulting in mass destruction of susceptible cells. This subfamily can be further subdivided 
into two genera; the Simplexviruses e.g. HSV-1 and 2; and the Varicelloviruses e.g. varicella 
zoster virus (VZV), feline herpes virus (FHV-1) and pseudorabies virus (PRV).
In contrast, the Betaherpesvirinae which comprise the cytomegaloviruses have a relatively 
long reproductive cycle. In tissue culture they produce slowly progressing lytic foci and 
infected cells frequently become enlarged (cytomegalia) both in vitro and in vivo. Members 
of this group can establish latent infections in glands and other tissues. They include human 
cytomegalovirus (HCMV) and equine herpesvirus 2 (EHV-2).
The final subfamily in this grouping are the Gammaherpesviriniae, which are lymphotrophic 
and specifically infect B and T lymphocytes. In the lymphocyte, infection is frequently 
arrested either at a pre-lytic stage with persistence and minimal expression of the viral 
genome, or proceeds to a lytic stage, causing cell death whilst producing complete virions. 
Examples are Epstein Barr virus (EBV).
1 .1 .3
Human herpesviruses.
Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) are among eight herpes viruses 
characterised to date that have man as their natural host (HSV-1, HSV-2, VZV, EBV, 
HCMV, HHV-6, HHV-7 and HHV-8). (See Table 1.1 and Figure 1.1)
HSV-1 and HSV-2.
See 1.1.4
VZV.
The primary disease caused by VZV is known as chickenpox or varicella. The virus enters 
via the respiratory tract and replicates in the lymph nodes (Minson, 1989; Ginsberg, 1990). 
Viraemia occurs and after an incubation period of roughly fourteen days, a fever ensues and 
vesicles form on the skin. In most cases infection occurs before the age of twenty. If the 
primary infection occurs in adulthood it can be particularly severe.
2
Table 1.1: The human herpesviruses.
Table showing the human herpesviruses, the group to which they belong, their most 
common associated illness, the genome size and its GC content.
From Subak-Sharpe and Dargan, 1998.
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Figure 1.1: Structures of human herpesvirus genomes.
Repeat regions are represented by open rectangles with the orientation of the repeats 
indicated by arrows. Unique regions are represented by horozontal lines.
Abbreviations are as follows:
UL unique long
Us unique short
T/Irl terminal/internal long repeat
T/Irs terminal/internal short repeat
D l direct repeat left
D r direct repeat right
MIr major internal repeat.
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During primary infection, VZV establishes latency in sensory ganglia of the spinal or cranial 
nerves where it persists for the lifetime of the host in the presence of neutralising antibodies. 
As with HSV, trauma and immune suppression can trigger reactivation. Reactivation leads to 
shingles (also known as herpeszoster), which manifests itself as vesicles and a severe pain at 
the distribution of the infected nerve.
HCMV.
HCMV has a prolonged lytic cycle that requires 5-6 days for completion (Smith and 
DeHaven, 1973). HCMV results in a variety of disorders, which include pneumonitis, 
encephalitis, neuropathy, retinitis, colitis and vasculitis (Wattre et al, 1995). It has also been 
implicated in organ transplant rejection (Arbustini et al., 1996; Vogelberg et al., 1996). The 
virus is able to transform cells in culture and several types of human malignancy have been 
linked to HCMV.
HCMV is the most common cause of severe intra-uterine infections (Minson, 1989; 
Ginsberg, 1990; Borucki and Pollard, 1994). HCMV also establishes latent infections.
EBV.
EBV infection occurs via the oral route and the virus replicates in the epithelium of the mouth 
and salivary ducts (Rickinson etal., 1985; Minson, 1989; Ginsberg, 1990).
Infection usually takes place within the first five years of life and produces a sub-clinical 
disease. When infection occurs after adolescence approximately fifty percent of patients 
display the clinical manifestations of the disease known as infectious mononucleosis (IM) or 
glandular fever. Symptoms include enlarged lymph nodes and spleen, abnormal 
lymphocytes in the blood and fatigue which can persist for months.
EBV can immortalise B-lymphocytes and the B-lymphocyte is a major site of EBV latency. 
EBV sequences are commonly found in at least two types of tumours, Burkitt's lymphoma 
(common in Africa) and nasopharangeal carcinoma (Southern Asia): thus the immortalisation 
functions may facilitate the development of certain tumours.
HHV-6 and HHV-7.
HHV-6 was first isolated from the blood of patients with lymphoproliferative disorders or 
AIDS (Salahuddin et al., 1986). Up to ninety percent of the population are asymptomatically 
infected with HHV-6, although infection in infants sometimes causes a mild skin rash called
3
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exanthum subitum (Yamanishi et al., 1988; Okuna et al., 1989) and acute febrile illness in 
young children (Pruksanonda et al., 1992; Hall, 1994). HHV-6 can replicate in CD4+ T- 
lymphocytes and there is evidence that the monocyte is a site of latency.
HHV-7 shares a number of common features with HHV-6 including replication in T- 
lymphocytes (Frenkel et al., 1990; Bememan et al., 1992; Lusso et a l, 1994), a similar 
genome organisation (Lindqueter and Pellet, 1991; Gompels et al., 1995; Secchiero et al., 
1995) and 50-60% nucleotide identity in the genomic regions which have been examined 
(Bememan et al., 1992). HHV-7 has also been isolated from the blood and saliva of 
immunosupressed and healthy subjects (Frenkel et al., 1990; Wyatt and Frenkel, 1992). 
Although HHV-7 has yet to be formally associated with any disease, there is evidence that it 
may be associated with some cases of exanthium subitum (Portolani et al., 1995).
HHV-8.
Attempts to identify infectious agents associated with Kaposi's sarcoma (KS) lesions 
suffered by AIDS patients located viral DNA sequences with close homology to regions of 
the EBV genome (Memar et al., 1995). Sequences of this herpesvirus, HHV-8, are found in 
peripheral blood mononuclear cells of KS+ patients: thus the presence of HHV-8 DNA 
appears to be essential for the aetiology of KS. Sequence analysis suggests that the HHV-8 
genome contains sequences which encode a D type cyclin and a number of other genes 
implicated in growth deregulation which may be relevant to its proposed role as a 
transforming vims.
1.1.4
Herpes simplex virus infections.
Two HSV serotypes have been identified: type 1 (HSV-1) and type 2 (HSV-2). They have 
been differentiated by pock size studies on chorioallontoic membranes (Rogers, 1973), 
neutralisation studies (Nahmias and Dowdle, 1968), monoclonal antibody-based assay and 
restriction enzyme analysis (Lonsdale et al., 1980; Bergstrom and Trybala, 1996). 
Serological studies have demonstrated that HSV-1 infections are generally acquired during 
childhood and that by sixty years of age, up to ninety percent of the population have 
antibodies to HSV-1 (Nahmias et al., 1970). HSV-2 infections are not usually acquired until 
puberty and are correlated with sexual activity. Johnson et al. (1989) show that the 
prevalence of HSV-2 antibodies increases with age in the post-adolescent years, an 
epidemiological pattern typical of a sexually transmitted disease (Kinghom, 1993).
4
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HSV causes genital infections, conjunctivitis, keratitis and herpetic Whitlow. HSV has a 
high worldwide prevalence. For example ocular infections affect approximately 500,000 
people in the USA each year (Binder, 1977). HSV encephalitis is the most commonly 
reported viral infection of the CNS, accounting for between 10 and 20% of all viral 
encephalitises in the USA. Immuno-compromised patients are at increased risk from HSV 
recurrent infection (Whitley, 1990).
Historically, HSV-1 has been associated with oral infections, while HSV-2 has been 
associated with genital infections. This distinction has become less valid, with 30-50% of all 
genital infections being caused by HSV-1 in some studies (Kalinyak et al., 1977; Smith et 
al., 1977; Kinghom, 1993) and 5-20% of oral infections being due to HSV-2. The 
increased incidence of genital herpes had lead to a corresponding increase in the level of 
neonatal herpes (Sullivan-Boyali etal., 1983; Whitley etal., 1991).
The lifecycle of HSV includes acute, latent and recurrent phases. During acute infection, 
HSV genes are expressed and the extent of disease is controlled by the cellular and humoral 
responses of the host. During latent infection, HSV gene expression is transcriptionally 
silent except for a limited region of the genome encoding the latency-associated transcripts 
(LATs).
During primary infection, the virus replicates lytically in the peripheral tissues around the site 
of infection and enters sensory nerves at the termini of axons of sensory neurones. A 
lifelong latent infection is established in neurones of the sensory ganglia and periodically, 
various stimuli including stress, exposure to ultra-violet light, hormonal changes and 
immunosuppression induce reactivation and the production of infectious virus. The 
reactivated virus then travels back to the tissues around the site of primary infection, where it 
may again replicate lytically, destroying cells and causing the formation of recurrent lesions.
1.1.5
Pathogenicity of HSV.
HSV-1 and HSV-2 are important human pathogens that cause a variety of diseases ranging 
from benign superficial cutaneous lesions to potentially fatal encephalitis (Whitley 1985). 
Identification of the genes that control pathogenic properties and elucidation of their function 
are of fundamental importance if we are to understand the basic mechanisms by which 
disease is initiated.
Various animal models have been used to study HSV pathogenicity, e.g. mouse, guinea pig, 
rabbit, rat and monkey. Several host factors controlling pathogenicity have been identified; 
namely, humoral immunity (McKendal etal., 1979) cytotoxic immunity (Nash et a l, 1985),
5
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interferons (Lopez, 1985), state of the skin and mucous membranes, age of host and route of 
inoculation (Sprecher et al., 1986; 1987). Another influencing factor is the body temperature 
of the host (Thompson and Stevens, 1983a and b). Viral factors affecting pathogenicity are 
virus strain and serial passage of the virus either in vivo (Kaemer et al., 1983) or in vitro 
(Goodman and Stevens, 1986).
1 . 1.6
Virion structure.
HSV virions are composed of four morphologically distinct structures, the core, an 
icosohedral nucleocapsid, an amorphous tegument surrounding the capsid and an outer 
envelope from which protrude the glycoprotein spikes (Dargan, 1986; Rixon, 1993; Beers et 
al., 1994). The HSV capsid is approximately 125 nm in diameter, exhibiting 5:3:2 axial 
symmetry and is composed of 162 capsomeres, of which 150 are hexameric (hexons) and 12 
pentameric (pentons), and 320 triplexes that provide intercapsomeric connections (Wildy et 
al, 1960; Schrag etal., 1989; Zhu e ta l, 1994). The capsid is composed of seven proteins: 
VP5 (UL19), VP 19c (UL38), VP23 (UL18), VP24 (UL26 N-terminal) and VP26 (UL35) 
(Gibson and Roizman, 1972: Cohen etal., 1980).
Three capsid forms have been observed and purified from wild type virus-infected cells: (i) 
empty capsids (type A) which lack viral DNA; (ii) intermediate capsids (type B) which lack 
viral DNA but possess two proteins not found in A capsids, VP21 (UL26 C-terminus) and 
VP22a (UL26.5), which occupy the inner capsid space and are thought to act as scaffolding 
proteins that are released when DNA packaging occurs (Rixon et al., 1988); and (iii) full 
capsids (type C) which contain viral genomes and are the intermediate precursors of mature 
virions that undergo tegumentation and envelopment before being released from the cell 
(Gibson and Roizman, 1972; Atkinson et al., 1978; Furlong etal., 1972; Rixon, 1993).
The capsid is surrounded by an amorphous layer known as the tegument (Roizman and 
Furlong, 1974). The dimensions of the tegument vary between herpesviruses and are 
thought to be determined, at least in part, by the virus (Nazerian and Witter 1970; McCombs 
etal., 1971).
The tegument may be more ordered than was previously thought, as specific interactions of 
various tegument components have been observed (Smibert etal., 1994; Elliott et al., 1995). 
It contains several viral factors that facilitate infection. Examples of these factors include 
Vmw65 (Ace et a l, 1988, 1989), the virion host shutoff factor (Kwong et a l, 1988) and 
possibly the immediate early (IE) proteins Vmwl75 and VmwllO (Yao and Courtney 
1989,1992; Yang and Courtney, 1995).
6
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The tegument is completely enclosed in a trilaminar envelope (Wildy et a l, 1960; Darlington 
and Moss, 1968) of mean diameter 180 nm which has surface spikes 8-10 nm long spaced 
5nm apart (Wildy et al., 1960) Use of monoclonal antibodies coupled with immunogold 
labelling allowed identification of some viral glycoproteins (gB, gC and gD) projecting from 
the virion envelope (Stannard et a l, 1987). To date 12 HSV glycoproteins have been 
identified: eleven of these glycoproteins have been detected in the envelope, with gK possibly 
being the only exception.
The glycoproteins are involved in adsorption, penetration, membrane fusion, cell to cell 
spread, envelopment, viral egress from the cell and prevention of superinfection. They also 
appear to play a role in evasion of the host immune system. It is likely that the glycoproteins 
function in envelopment by specifically interacting with virus tegument proteins (Zhu and 
Courtney, 1994). In addition to the glycoproteins, the envelope contains cell lipids (Asher et 
al, 1969).
Over half of the eighty plus proteins encoded by HSV-1 are thought to be present in the 
virion or involved in virion assembly.
1.2
The HSV-1 genome.
Herpesviruses have a large single dsDNA genome which varies in size, GC content and the 
arrangement of the major repeat regions (Becker et a l , 1968; McGeoch, 1989).
The sequence of the HSV-1 strain 17 genome, published in 1988, contains 152,260 residues 
in each strand (McGeoch et al, 1985, 1986; Perry and McGeoch, 1988). However, the 
existence of variation in repeat copy number means that this number is not fixed. The genome 
of HSV-2 has now been completely sequenced (Dolan et al, 1997), and is extremely similar 
to HSV-1 with a slightly higher GC content, at 68.3% in comparison to 67% (Keiff et a l, 
1972; Davison and Wilkie, 1983; McGeoch et al, 1988a).
HSV DNA consists of two covalently joined segments, the long (L) and short (S) 
representing 82% and 18% of the genome respectively i.e. 100% of the entire copy number. 
Each segment contains a unique region (UL and Us respectively) flanked by repeats in 
opposite orientation to each other, termed the internal (IR) and terminal (TR) inverted repeats; 
hence the internal repeat in the long region is the IRL and the terminal repeat TRL, while those 
in the short region are the IRS and TRS respectively (Sheldrick and Berthelot, 1974; Delius 
and Clements, 1976). At each of the termini there is a short (250-500 bp) direct repeat 
termed the a sequence. It is present in variable numbers at the long terminus with only one 
copy being found at the short terminus (Wilkie, 1976; Wagner and Summers, 1978; Roizman
7
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1979; Davison and Wilkie, 1981). There is also at least one copy in an inverted orientation at 
the L-S junction. Both genomic termini display an overhanging residue leaving a 3’ hydroxyl 
group free (Mocarski and Roizman, 1982). Figure 1.2.
Us and UL can invert relative to one another producing equimolar proportions of four isomers 
(Clements et al., 1976; Wilkie and Cortini, 1976; Roizman, 1979). The four isomers are 
termed P (prototype), which has been assigned as the prototype to facilitate mapping 
(Roizman, 1979; McGeoch et al, 1988a); IL (inversion of the long segment); Is (inversion of 
the short segment); and ISL (inversion of both the long and short segments).
1 . 2.1
The HSV-1 a sequence.
The a sequence is highly conserved but contains variable numbers of repeat elements. This 
variation is seen both within (Wagner and Summers, 1978) and between strains (Locker and 
Frenkel, 1979). Tandem reiterations of the a sequence occur 1-5 times at the L-terminus, but 
only one copy exists at the S-terminus (Wilkie, 1976; Wagner and Summers, 1978).
The HSV-1 strain F a sequence has been analysed in depth and is composed of the following 
elements: a 20 bp direct repeat (DR1), a 65 bp unique sequence (Ub), between 19 and 23 
copies of a 12 bp direct repeat (DR2), 2-3 copies of a 37 bp direct repeat (DR4) and a 58 bp 
unique sequence (Uc) followed by another DR1 (Mocarski and Roizman, 1981). Thus the a 
sequence can be represented as:
DR 1 -Ub-DR2n-DR4m-Uc-DR 1
Adjacent a sequences share the intervening DR1 (Mocarski and Roizman, 1981; see section 
1.2.2). The variation in size of the a sequence is partly determined by the varying numbers 
of copies of DR2 and DR4. A complete DR1 is formed on circularisation since the terminal a 
sequence of the L component has a truncated DR1 composed of 18 bp and a one nucleotide 3’ 
overhang, while the a sequence of the S-terminal ends with a DR1 consisting of only one bp 
and one 3’ overhang (Mocarski and Roizman, 1982).
It has been demonstrated that deletion of the Ub or Uc domains does not affect the ability of 
the a sequence to mediate genome inversion, whereas deletion of DR4 causes a dramatic 
reduction in inversion (Chou and Roizman, 1985). It has also been demonstrated that the a 
terminus is dispensable for isomerisation of the HSV-1 genome (Martin and Weber, 1996). 
The a sequence mediates genome circularisation, site specific recombination and cleavage and 
packaging of HSV DNA (Davison and Wilkie, 1983a; Poffenberger and Roizman, 1985).
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Figure 1.2: Structure of the HSV-1 genome.
A: the HSV-1 genome is shown, with unique sequences as solid lines (US and UL). The 
repeats TRL, IRL, IRS and TRS are illustrated as boxes with their component parts a, b, c 
and a', b', c' designated, b' and c' are identical to b and c, but in inverse orientation, a' 
and a are repeat elements in inverse orientation and variable in copy number.
B: below the genome representation, the isomerisation of the HSV-1 genome is 
illustrated. The four isomers are: P (prototype), IL (L inverted with pespect to P), Is (S 
inverted with respect to P) and ISL (S and L inverted with respect to P).
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1 . 2.2
Cleavage and packaging of DNA.
Capsid assembly and packaging of the viral DNA occurs in the nucleus. Following 
replication of the HSV-1 genome, the concatameric DNA is cleaved into unit length virus 
genomes and packaged into pre-formed viral capsids by a tightly coupled mechanism 
involving amplification of a sequences (Deiss and Frenkel, 1986). This produces a packaged 
viral genome with a free S-terminus containing a DR1 consisting of a single bp and a 1 nt 3' 
extension, and an L-terminus consisting of between one and five copies of the a sequence 
ending in a DR1 containing 18 bp and a 1 nt 3' extension, so that an intact DR1 is formed 
when the ends join together.
Two highly conserved regions were identified in the Ub and Uc regions of the a sequence, 
pac-l andpac-2 respectively, which appear to be essential for the cleavage/packaging process 
(Deiss et al, 1986). They were discovered after Stow et al. (1983) noted that the ability of a 
plasmid containing S to be packaged by a helper virus required the presence of an a sequence 
in the plasmid.
Deiss et a l (1986) proposed a model for the packaging and cleavage process. The model 
proposes that a protein binds to an a sequence and in turn binds to a site on the capsid. The 
DNA is then extruded into the capsid until another a sequence in identical orientation comes to 
be packaged, whereupon one of the juxtaposed a sequences is cleaved. The cleaved a 
sequence is then repaired and duplicated. Once duplicated, cleavage occurs within the shared 
DR1 sites of the a sequences.
The capsid is enveloped by budding through patches of tegument proteins and immature 
glycoproteins on the inner nuclear membrane. Newly synthesised precursors of gB, gC and 
gD of HSV-1 are associated with calnexin, a membrane-bound chaperone in the endoplasmic 
reticulum (Yamashita et al, 1996). The virion reaches the Golgi where the glycoproteins are 
glycosylated to their mature form (Darlington and Moss, 1969; Schwartz and Roizman, 1969; 
Johnson and Spear, 1982). It is unclear whether the envelope present on released virions is 
derived from the inner nuclear membrane or derived from the Golgi membrane, since two 
possible pathways of envelopment can be envisaged (Rixon, 1993). There is general 
agreement that the initial stage involves the capsid budding through the inner nuclear 
membrane. The differences of opinion are as to the route by which virions leave the 
perinuclear cistema. The first pathway predicts that after budding through the inner 
membrane the envelope is lost by fusion with the outer membrane and that the final virion 
envelope is formed by budding through the Golgi membrane. Evidence supporting this 
pathway comes from the betaherpesviruses, where the tegument is a dense structure easily 
identifiable in electronmicrographs. Particularly clear pictures have been obtained for HHV-6
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which suggest that capsids become enveloped by budding through the inner nuclear 
membrane and are then de-enveloped at the outer nuclear membrane before release into the 
tegusome. Fully tegumented capsids are then transported to the cytoplasm, where they 
become enveloped by budding into cytoplasmic vesicles.
In the second pathway, after gaining the envelope from the inner nuclear membrane, the 
nucleocapsid enters a vesicle derived from the outer nuclear membrane. The vesicle-enclosed 
virion fuses with the Golgi membrane thus releasing the virion into the Golgi and preserving 
the envelope derived from the inner nuclear membrane. Evidence for this pathway again 
comes from EM studies, and no conclusive evidence has been found to support either theory. 
It is possible that different herpesviruses use different pathways or even that a single 
herpesvirus may use either pathway in different cell types.
1.2.3
HSV glycoproteins.
Membrane glycoproteins are extremely important to the virus since they mediate its entry into 
the cell, cell-to-cell spread of infection, cell fusion, envelopment, egress, and immune 
evasion (section 1.4). They also play an important role in tissue tropism and host range. 
(See Table 1.2 and Fig 1.3).
HSV-1 encodes at least 12 glycoproteins (gB, gC, gD, gE, gG, gH, gl, gJ, gK, gL, gM and 
gN). All, with the possible exception of gK, are incorporated into the virion envelope and 
Handler et al. (1996a) estimate that the total number of glycoprotein molecules in the envelope 
to be in excess of 100,000. Of these glycoproteins five, (gB, gH, gL, gM and gN) have 
been found in every member of the herpesvirus family analysed so far (Mettenleiter, 1994; 
Spear, 1993) (Table 1.3). The highest degree of conservation is found within the gB 
homologues, followed by glycoprotein homologues of gM and gH. Glycoproteins G, K and 
possibly E and I are only found in alphaherpesviruses (Spear, 1993a). Their precise 
functions have not all been defined, although five of them, gB, gD, gH, gK and gL, have 
been shown to have an essential role in virus infectivity (Stannard et a l, 1996). 
Glycoprotein C has an important role in binding heparan sulphate (HS) and complement. 
Glycoprotein K is essential for virus release, and syncytial mutations or mutations in cell to 
cell spread have been mapped to this gene. Within the virion and in infected cells gE and gl 
(Dubin et al., 1990; Johnson et al., 1988), as well as gH and gL (Hutchinson et a l,  1992; 
Roop et al., 1993) are heterodimers, and gB (Claesson-Welsh and Spear, 1986) is 
homodimeric. In addition a proportion of gC can be cross-linked into a heterodimeric
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Figure 1.3: Roles of glycoproteins.
1. Adsorption.
2. Penetration.
3. Fc binding receptors, C3b binding receptors.
4. Receptors for other ligands.
5. Envelopment.
6. Egress.
7. Release.
8. Cell fusion.
9. Direct cell-to-cell spread.
gE/gl, gC
Table 1.2: 
Gene
UL1
UL10
UL22
UL27
UL44
UL49A
UL53
US4
US5
US6
US7
US8
HSV-1 glycoproteins 
Glycoprotein
Glycoprotein L
Glycoprotein M 
Glycoprotein H
Glycoprotein B 
Glycoprotein C
Glycoprotein N
Glycoprotein K
Glycoprotein G
Proposed 
Glycoprotein J
Glycoprotein D 
Glycoprotein I 
Glycoprotein E
Role
complexes with gH 
(UL22)
virus entry, viral 
spread
virus entry, 
complexes with gL 
(ULl)
virus entry
virus entry, binds 
complement
syn locus, egress
role in virus entry
complexes with gE in 
Fc receptor,
Requirement
essential
non-essential
essential
essential
non-essential
non-essential
essential
non-essential
non-essential
essential
non-essential
non-essential
Table 1.3: Glycoproteins of HSV-1 and homologous proteins in other 
members of the alphaherpesvirinae.
HSV-1 PRV vzv SW MDV EHV-1 BHV-1
gD gD
(gp50)
- - gD gD gD (glV)
gE gE (gl) gE (gpl) gE gE gE gE
gG gG (gX) - - - gG gG
gl gl(gp63) gi(gpIV) gl gl gl gl
gJ - - - - - gJ (US5)
gB gB (gH) gB
(gpn)
? gB
(gpB)
gB
(gpl 4)
gB (gl)
gC gC (gni) gc
(gpY)
? gc
(gpA)
gc/ gc (gni)
gH gH gH
(gpni)
? gH gH gH
gK ? gK ? ? gL ?
gL gL gL ? ? gK ?
gM ? gM ? ? gM ?
gN gN gN ? ? gN gN
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complexed form where gB is cross-linked to gC and gC to gD (Zhu and Courtney, 1988; 
Handler et al, 1996).
Glycoprotein B.
HSV-1 gB is a virion associated glycoprotein that has a role in virus adsorption, penetration, 
cell-to-cell spread and cell fusion (Navarro et al, 1992); it is also a specific determinant of 
HSV-1 neuroinvasiveness (Yuhasz and Stevens, 1993).
One of the important features of gB is that it binds HS moieties on the cell surface. It has 
been shown that dextran sulphate can functionally substitute for cellular glycosaminoglycans 
to allow initiation of HSV infection and that this dextran sulphate stimulation of infection is 
primarily mediated by gB (Dyer et al, 1997).
HSV-2 gB also interacts with cell surface glycosaminoglycans during virus attachment 
(Williams and Strauss, 1997).
Cell surface heparan sulphate proteoglycans also serve as receptors for the binding of HCMV 
gB (gp UL55), although HCMV can attach to the cell surface in the absence of heparan 
sulphate proteoglycans via an unidentified nonheparin component (Boyle and Compton, 
1998).
In the case of PRV gB (gll), monoclonal antibodies inhibit virus penetration but do not affect 
adsorption. Glycoprotein C negative PRV infects target cells via a heparan sulphate 
independent pathway, again suggesting that PRV gB does not productively interact with 
heparan sulphate (Mettenleiter 1990; Klupp et al, 1997), although it plays an essential role in 
viral penetration (Byrne et al, 1995).
The conserved nature of gB and its gene in different herpesviruses suggests that different gBs 
should be readily interchangeable, gB of HSV-1, HSV-2, PRV (although not functionally) 
and BHV-1 all bind HS. However, complete functional equivalency and interchangeability 
of the gB gene from different viruses has only been demonstrated for HSV-1 and HSV-2 
(Lin etal., 1996). In the case of less related viruses such as PRV and BHV-1 or PRV and 
HSV-1, unidirectional complementation of the gB polypeptide occurs (Mettenleiter and 
Spear, 1994; Rauh et a l, 1991). Rauh et a l, (1991) produced a gB negative PRV mutant 
that grew normally on PRV gB complementing cells and also on BHV-1 gB expressing cells. 
The PRV mutants grown on cells expressing BHV-1 gB incorporated BHV-1 gB into their 
envelopes and became susceptible to neutralization by anti BHV-1 gB monoclonal antibodies. 
The PRV gB expressing cell lines did not complement a BHV gB mutant, indicating that 
BHV-1 gB can functionally replace PRV gB but not vice versa. Mettenleiter and Spear 
(1994), used a PRV gB expressing cell line and demonstrated that it complemented gB
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negative HSV-1, however this complementation was again unidirectional since a HSV-1 
expressing cell line did not complement gB negative PRV. The functional complementation 
of PRV gB for HSV-1 gB may be due to the significant homology between the glycoproteins 
at the amino acid level (Robbins et al, 1987).
Glycoprotein B negative virus cannot enter cells but its infectivity is increased by 
polyethylene glycol (PEG) treatment which promotes cell fusion (Cai et al, 1988).
HSV-1 gB is one of the four regions of the viral genome that is linked to syncytial mutation. 
Mutations affecting the cytoplasmic C-terminal domain of gB induce a syncitial phenotype 
(De Luca et al, 1982; Bzik et al, 1984; Cai et al, 1988).
Glycoprotein C.
HSV-1 gC is not essential for virus production in cell culture, although it has several 
accessory functions including a role in viral attachment to the cell surface through HS 
moieties and the ability to bind the C3b component of complement (Padilla et a l, 1997; 
section 1.4.5).
While gC enhances viral entry, it is not required for syncytium formation and has actually 
been shown to inhibit the fusion of some cultured cells (Manservigi et a l, 1977, Novotny et 
al, 1996). Many syncytial HSV mutants do not express gC, perhaps as a result of this 
inhibition (Spear 1993).
Purified gC inhibits complement activation. Glycoprotein C-negative mutants are rapidly 
neutralised in a process mediated by components of the classical component pathway. 
Glycoprotein C has been shown to mainly protect against antibody independent neutralization 
which indicates a role for gC early in infection before antibodies have developed (Friedman et 
al, 1996).
Viruses deleted in PRV gC are impaired in adsorption (Schreurs et a l, 1988), penetration 
(Mettenleiter, 1989) and virus release from infected cells (Schreurs et a l, 1988). Mutants of 
PRV defective in gC are only slightly less virulent in mice and chickens than wild type virus, 
although mutants defective in both gC and gE are avirulent (Zsak et al; 1992, Kritas et al., 
1994a and b).
BHV-1 gC has also been shown to be involved in virus entry (Liang et al, 1991a and b). 
Liang et al.. (1991b) made a recombinant BHV-1 virus that expressed PRV gC in place of 
BHV-1 gC. This recombinant virus was shown to be as efficient in mediating virus 
attachment and penetration as the wild type virus. Thus it was concluded that PRV gC and 
BHV-1 gC share complementary functions.
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Glycoprotein D.
Glycoprotein D is a viral envelope glycoprotein that has been studied extensively using 
immunological, biochemical and genetic approaches. It is essential for viral entry (Willis et 
al, 1998) and glycoprotein D negative mutants have been shown to be severely compromised 
in neuronal spread (Dingwell et al, 1995).
Glycoprotein D mediates the stable binding that follows the action of gB and gC by binding 
gD receptors, (discussed in section 1.4.2) that are limited in number.
Glycoprotein D monoclonal antibodies can neutralise HSV infectivity by blocking penetration 
of the virus at the cell surface (Fuller and Spear, 1987), due to a block in fusion between the 
virion envelope and plasma membrane. Neutralised virus binds to cells and accumulates on 
the surface with reversal of the effect of neutralising antibodies again being achieved by 
treatment with PEG. Cells expressing HSV gD are resistant to HSV entry as a result of gD 
mediated interference. HSV strains differ in their sensitivity to this interference, which 
blocks penetration but not binding. Mutations in gC and gK can confer partial resistance to 
this gD-mediated interference (Pertel and Spear, 1997).
It is proposed that the role of gD in cell to cell spread may be partially associated with its 
ability to bind mannose-6-phosphate receptors (MPRs) (Brunetti et a l,  1998). MPRs are 
involved in a well characterised pathway through which lysosomal enzymes are directed to 
lysosomes via a network of endosomal membranes. HSV can form plaques under conditions 
prohibiting interaction with MPRs (e.g. using blocking antibodies, ligands and soluble MPR) 
and thus it was proposed that this interaction functions during egress or cell to cell spread 
(Brunetti et a l, 1995). In their later paper Brunetti et a l (1998) report that the virus can be 
directed to endosomes by both mannose-6-phosphate-dependent and independent 
mechanisms.
BHV-1 gD is identical to HSV-1 gD in that it is involved in virus entry and direct cell to cell 
spread. The PRV homologue (gp50) is an envelope glycoprotein, essential for penetration 
but not for direct cell to cell spread (Peeters et al, 1993; Schroder et al, 1997).
Glycoprotein E.
This glycoprotein was shown to be non-essential by Neidhardt et a l (1987). However, gE 
negative HSV-1, PRV and BHV-1 are less efficient at establishing latency and are therefore 
less likely to be reactivated than wild type virus. Glycoprotein E is an Fc binding 
glycoprotein (Bauke and Spear, 1979) and forms a noncovalently linked heterodimer with gl 
(see section 1.4.4). Glycoprotein E alone acts as a lower affinity IgG receptor binding IgG 
aggregates but not IgG monomers, while the gE:gI complex acts as a higher affinity receptor,
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binding both IgG monomers and aggregates (Dubin et a l,  1990). Fc binding activity may 
prevent complement mediated lysis of infected cells and enveloped virions and may also 
protect against Fc-facilitated phagocytosis (Bell et al., 1990). The gE:gI complex also 
facilitates neuron to neuron spread of HSV-1 and its cell to cell spread (Dingwell et a l 1995). 
Chateijee et a l (1989) implicated gE in the induction of cell fusion.
BHV-1 gE has a central role in BHV-1 spread, acting through cell-to-cell spread which is a 
major mechanism of BHV-1 in vivo virulence (Rebordosa et a l 1996).
PRV gE and gl are important in virulence and viral spread, and show Fc receptor binding 
ability for swine IgG but not that of other species (Zuckermann et a l,  1988) They form a 
hetero-oligomer that facilitates the maturation and intracellular transport of both proteins to the 
plasma membrane of cells, although both gE and gl can reach the cell surface independent of 
each other's expression (Whealy et a l, 1993). PRV gE (gl) plays a role in virus release from 
infected cells (Mettenleiter et a l, 1987). Mutants defective in gE are only slightly less 
virulent in mice and chickens than wild type virus, while mutants lacking both gE and gC are 
avirulent. Glycoprotein E of PRV is an accessory protein that promotes cell fusion. 
Glycoprotein E negative mutants of PRV are deficient in their ability to form syncytia, 
forming only small plaques on some cell types, these mutants spread mainly by adsorption of 
released virus to uninfected cells (Zsak et al, 1992). Glycoprotein C mutants are reported to 
spread mainly by means of direct cell to cell spread, therefore a combination of both 
mutations results in a defect of adsorption of released virus as well as direct cell to cell 
spread.
Homologues of gE have been found in all members of the alphaherpesvirinae, indicating an 
important and conserved role in the biology of the alphaherpesviruses. The homologous 
proteins appear to have little amino acid identity, but HSV-1, PRV, BHV-1, EHV-1, S W  
and VZV share two clusters of closely spaced cysteine residues which are thought to play an 
important part in the function of gE (Jacobs, 1994).
Glycoprotein G.
HSV-1 gG is the product of the US4 gene (Richman et a l, 1986) and has the predicted 
structure of a class 1 membrane protein. Mutants lacking gG are viable in culture (Weber et 
al, 1987; Longnecker et al, 1987) and its function is unknown. Balan et a l (1994) reported 
that gG-negative mutants do not have altered particle/infectivity ratios, nor do they show 
defects in growth or spread in BHK cells.
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Glycoprotein H.
Glycoprotein H forms a complex with gL that effects the folding and surface expression of 
gH. If gH is expressed in the absence of other viral proteins it is antigenically abnormal, is 
not processed and not expressed at the cell surface. However, when gH is expressed with 
gL it is antigenically normal, processed normally, and transported to the cell surface. Similar 
observations are made in the case of gL. This indicates that it is the hetero-oligomer of gH 
and gL that is incorporated into virions and transported to the cell surface. A 1:1 ratio exists 
between gH and gL in infected cells, and probably also virions (Hutchinson et al., 1992). 
Glycoprotein H is required for membrane fusion but is dispensable for receptor binding. It is 
conserved in all sequenced herpesviruses and adsorption of gH negative virions to cells 
blocks superinfection (Forrester et al, 1992). Monoclonal antibodies for gH of HSV-1 can 
block viral penetration without inhibiting the adsorption of vims to cells (Fuller et al., 1989). 
Glycoprotein H may have a role in viral egress from cells, since Buckmaster et al. (1984), 
showed that an anti-gH antibody inhibited plaque formation when added in the overlay 
following vims adsorption. Mutant vimses with altered gH are retained within cells (Desai et 
al., 1982): targeting of gH to the RER results in the release of non-infectious virions from 
infected cells, while infectious virions containing gH are retained in the cytoplasm 
(Jaychandra et al., 1997).
Glycoprotein H may also be involved in cell fusion, as a gB syn mutant with a mutation in 
gH does not produce a syncytial phenotype. Glycoprotein H negative virions bind cells 
while being unable to enter them unless PEG treatment is used (Forrester et al. 1992). 
Glycoprotein H of PRV is a stmctural component of the virion and also complexes with gL. 
PRV mutants lacking gH are not defective in primary or secondary attachment but are not 
infectious as PRV gH is essential for penetration and propagation of vims in cell culture and 
in the nervous system of mice (Babic et al., 1996).
Glycoprotein I.
Glycoproteins E and I form a heterodimer which acts as an Fc receptor and also facilitates 
cell-to-cell spread of vims. Glycoprotein I not required for the infection of cells by 
extranuclear vims (Dingwell et al., 1995). See glycoprotein E and section 1.4.4.
The fact that gE and gl form a complex makes it difficult to estimate the contribution of either 
glycoprotein to the complex's biological function as deletion of either component leads to 
inactivation of the complex.
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Glycoprotein J.
No function has yet been ascribed to the putative gJ. The US5 ORF was identified by 
McGeoch et a l (1985) who observed that the predicted translation product contained a N- 
terminal signal peptide, a potential transmembrane anchor and a single N-glycosylation site. 
The gene product was named gJ (Roizman and Batterson, 1985), but has not yet been 
identified. Disruption of the US5 gene did not significantly alter virulence in vivo (Weber at 
al., 1987). Balan et a l (1994), showed that disruption of US5 had no effect on particle to 
p.f.u ratios, or on the growth of the virus in BHK cells and no effect on viral pathogenicity in 
the mouse ear model.
Glycoprotein K.
Unlike other glycoproteins, gK is apparently not a component of the viral envelope.
The HSV-1 glycoprotein gK (Hutchinson et a l, 1992b) is the product of the UL53 gene 
(Debroy et al, 1985, McGeoch et al, 1988a). It is not absolutely essential for the production 
of infectious virus in actively replicating cells but is needed for efficient envelopment and 
transport of infectious virions to the extranuclear space. This glycoprotein is also involved in 
egress of HSV (Hutchinson et al, 1995b). Glycoprotein K is thought to play an important 
role in regulating membrane fusion and syncitial mutations arise more frequently in UL53 
than any other HSV gene (Ruyechan et a l, 1979; Bond and Person, 1984; Pogue-Geile and 
Spear, 1987; Jaychandra et al, 1997). In contrast to all other HSV glycoproteins described 
to date, gK accumulates in the perinuclear and nuclear membranes of cells; the other 
glycoproteins are transported to the surfaces of infected cells (Hutchinson et al, 1995a). 
Unlike HSV-1, PRV gK is a structural component of the virion. It is involved in virus 
release but is not required for virus entry although deletion of gK results in a significant 
delay in penetration that can be rescued by phenotypic complementation on gK expressing 
cells (Klupp etal., 1998). PRV gK is required for productive virus replication, and has an 
important role in egress thought to be the prevention of immediate re-entry of released 
infectious virions.
Glycoprotein L.
Glycoproteins H and L are dependent on each other for proper processing and expression 
(Hutchinson et a l, 1992a,). Glycoprotein L lacks a transmembrane domain but stably 
associates with membranes through oligomerisation with gH (Novotny et al, 1996).
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Like HSV, the gH:gL complex has a role in penetration of BHV-1 but not its attachment 
(Littel van den Hurk et al, 1996).
Glycoprotein M.
HSV-1 gM differs from all other cell-associated HSV glycoproteins studied to date in that it is 
highly hydrophobic (Baines and Roizman, 1993), having eight potential transmembrane 
regions (McGeoch et a l,  1986; MacLean et a l,  1993;). There are also two potential N- 
linked glycosylation sites present. Mutations in the gene have no clear phenotype as yet.
PRV UL10 contains eight hydrophobic regions and a N-glycosylation site. PRV UL10 is 
not essential for productive replication of PRV in cell culture.
The gM genes of HSV-1 and PRV are not essential for replication in vitro or in vivo (Baines 
and Roizman, 1991, Dijkstra et a l,  1996, MacLean et a l,  1991, 1993). MacLean et a l,
(1991) report that the HSV-1 UL10 product is a glycosylated membrane protein required for 
optimal virus growth in vitro and in vivo. PRV mutants grow to lower titres, demonstrate a 
lag in penetration of cell compared to the wild type (Dijkstra et a l 1996) HSV-1 and PRV 
mutants are impaired for peripheral growth and spread within and/or to the nervous system in 
mice (Dijkstra et a l, 1996, MacLean et al, 1993) They are defective for cell to cell fusion in 
combination with a gB syn mutant (Davies Poynter et a l,  1994), suggesting that gM may 
play a role in membrane penetration.
In HSV-1 and PRV the deletion of gM had little effect on phenotype, and thus the 
conservation of gM homologues throughout the herpesviruses is puzzling. Glycoprotein M 
demonstrates a degree of conservation similar to that for the essential gH and gK homologues 
(Dijkstra et a l, 1996).
Wu et a l (1998), reported that BHV-1 gM forms a disulphide-linked heterodimer with gN. 
They also suggest that since all known gM and gN homologues have similar patterns of 
hydrophobic domains and cysteines the two proteins may be linked by disulphide bonds in all 
herpesviruses. Since both gM and gN are conserved in the herpesviruses it may be that this 
association is a functional complex.
Glycoprotein N.
Glycoprotein N is the product of UL49A, and a 72 transcript has been mapped to this
genomic region (Hall et a l, 1982, Barnett et al., 1992). Homologues of HSV-1 UL49.5 
have been found in all herpesvirus genomes analysed so far (Jons et al, 1996).
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HSV-1 UL49A encodes a small virion protein that is linked by a disulphide bond to a 
tegument protein with no evidence of glycosylation (Adams et a l, 1998).
Glycoprotein N of PRV has homology to that of HSV-1. It is an O-glycosylated structural 
component of the viral envelope.
Like HSV-1, BHV gN is apparently unglycosylated and is an envelope protein (Liang et a l, 
1996).
1.3
HSV latency
HSV has evolved a complex interaction with the peripheral nervous system (PNS) whereby it 
can survive throughout the life of the infected individual in a latent state and thus evade the 
immune response of the host. Following primary infection and active replication at peripheral 
sites, virus attaches to the sensory nerve terminals (Vahlne et a l, 1978), enters them and 
travels centripetally via axons to neuronal cell bodies within the sensory ganglia (Cook and 
Stevens, 1973; McLennan and Derby, 1980). The viral genome is then uncoated, released 
into the neuronal nucleus and converted into a non-linear form (Rock and Fraser, 1983, 
1985; Efstathiou et a l, 1986). In the case of HSV-1 these are mainly trigeminal ganglia 
(Bastian et al, 1972; Baringer and Swoveland, 1973; Efstathiou et al, 1986) and in the case 
of HSV-2 dorsal root ganglia (DRG) (Baringer, 1974; Galloway et a l, 1979,1982). Latent 
virus has also been recovered from cells of peripheral tissues e.g. human corneas (Shimeld et 
al, 1982; Cook, 1988) and experimentally infected rabbits (Cook et al, 1987) and mice 
(Openshaw, 1983) as well as the footpads of experimentally infected mice (Al-Saadi et al., 
1983). Latency in peripheral tissues is thought to be a secondary sequelae to primary HSV 
infection (Hill, 1985) and its biological relevance is unknown.
1 .3 .1
Animal models of latency.
Several animal models have been developed to study HSV latency. The most commonly 
used is the mouse (Stevens and Cook, 1971; Walz et a l, 1974; Al-Saadi et al, 1983; 
Clements and Subak-Sharpe, 1983, 1988). Other systems used include rabbit (Nesburn, 
1967, 1977), guinea pig (Scriba, 1975, 1976) and monkey (Reeves et a l, 1976, 1981). 
Various peripheral injection sites are employed: footpad (Stevens and Cook, 1971; Scriba, 
1975), eye (Nesburn et a l, 1967), ear pinnae (Hill et a l, 1975, 1978, 1980), flank 
(Underwood and Weed, 1974; Whitby et al, 1987) and vagina (Scriba, 1976). Whilst none
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of these models can fully mimic the pathogenesis of HSV infection in humans with regard to 
inoculation site, input dose, reactivation triggers or immune response, they have provided 
valuable information on the three basic components of latency - establishment, maintenance 
and reactivation. Unfortunately, none of the above models provide the ideal system to study 
all three components in a single host.
The first demonstration that HSV could establish a latent infection in sensory ganglia 
followed footpad inoculation of mice and the subsequent explantation of DRG that released 
infectious virus after a period in tissue culture (Stevens and Cook, 1971). This fundamental 
study provided the basic model of in vitro reactivation as a measure of latent infection. As a 
consequence of this study it was later demonstrated through explantation of human sensory 
ganglia (post mortem dissection) that HSV resides in a latent state here ( Warren et al., 1978). 
Extensive use has been made of the footpad model (Stevens and Cook, 1971; Walz et al., 
1974; Al-Saadi et al., 1983; Clements and Subak-Sharpe, 1983, 1988) and it has allowed the 
demonstration that HSV can also establish a latent infection within cell populations of the 
footpad skin (Al-Saadi et al., 1983, 1988) . Infection via the footpad does not provide a 
system to study reactivation in vivo as recurrences are neither spontaneous nor inducible 
(Hill, 1985).
Another widely used model consists of peripheral inoculation of the eye in both mice (Knotts 
et al., 1974) and rabbits (Nesburn et al., 1967; Stevens et a l, 1972). In the mouse eye 
model spontaneous or induced reactivation is not reproducible (Harbour et al., 1983; Shimeld 
et al., 1990) and thus only factors affecting establishment and maintenance in vivo can be 
examined. However in the rabbit, reactivation can be induced at will by iontophoresis of 
adrenaline into the eye (Nesburn et al., 1977). However, frequent spontaneous recurrent 
shedding also takes place (Nesburn etal., 1977) and this makes interpretation of reactivating 
factors difficult.
Another mouse model of HSV latency (Sawtell and Thompson, 1992a) is based on the strong 
correlation between fever and HSV reactivation in humans (Boak et al., 1934; Roizman and
Sears 1990). Latently infected mice are immersed in hot water (42 °C) to induce mild
hyperthermia, with the rate of change in core temperature being controlled by the depth of 
immersion of the animal. Using this method virus can be isolated from the trigeminal ganglia 
of mice within 14 hours post induction: the approximate time required for one round of viral 
replication in culture. It is not clear if viral shedding occurs at the peripheral inoculation site. 
HSV-2 latency has historically been studied following intravaginal inoculation of guinea pigs 
which results in vaginal recurrences (Scriba, 1976). This system has been hampered by high 
incidence of viral persistence in the cells of the vagina (Stanberry et al., 1985).
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While these in vivo models have produced valuable information regarding the pathogenesis of 
HSV infection and the role of viral factors in latency, their use in the investigation of 
molecular mechanisms controlling latency is limited due to the complexity of the contribution 
of host factors and immune system to latency, the expense of the models and the fact that 
only a small proportion of neurons are simultaneously reactivated. In vitro latency systems 
are required in order to help characterise establishment, maintenance and reactivation at the 
molecular level.
1 .3 .2
In vitro models.
In the laboratory, latency is defined as the ability to isolate infectious virus from explant 
cultures (of sensory ganglia) after a period of time in culture, where virus has not been 
isolated from the explant tissue homogenate immediately post explantation.
In vitro systems can be divided into three types, 1) those using primary cultures from the 
ganglia of rodents, 2) cell-lines of neuronal origin, 3) non-neuronal tissue culture cells.
Such systems should show the following characteristics: 1) viral genomes should persist in 
cell nuclei in the absence of infectious virus; 2) viral genomes should be non-linear, as they 
are in vivo; 3) transcription of the genome should be repressed or limited to the LAT region; 
and 4) latent virus should be capable of reactivation producing infectious vims.
Perhaps the most significant in vitro system using primary neuronal cultures involved the 
treatment of cervical ganglia from neonatal rats with collagenase, followed by dissociation 
onto a growth surface and treatment with fluorodeoxyuridine (Wilcox and Johnson, 1987).
A system developed by Wigdahl et a l, (1983), used isolated rat foetal dorsal root ganglia. 
C l300 mouse neuroblastoma cells (Nilheden et al., 1985) and HFL cells (O’Neill et al., 
1972; Russell and Preston, 1986) are also used as in vitro model systems.
1.4
Role of HSV glycoproteins in the HSV lytic cycle
1 .4 .1
Adsorption
The initial interaction between HSV and cells is the adsorption of the vims to the cell surface 
and the subsequent fusion of the virion envelope with the plasma membrane, either at the cell 
surface or in endocytic vesicles (Fan and Sefton, 1978; Marsh, 1984). Early electron
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microscopy (EM) studies suggested that both mechanisms of viral entry are used (Morgan et 
al.\ 1968; Dales and Silverberg, 1969). However it has since been shown that compounds 
known to inhibit the endocytic process do not inhibit entry of HSV (Wittels and Spear,
1991). It has also been shown that virus internalised in an endocytic vesicle does not 
establish a lytic infection in the host cell, most probably because it is degraded in the vesicle 
(Campadelli-Fiume et al, 1988).
Current opinion favours entry by direct fusion of the virion envelope with the cell membrane, 
resulting in the release of nucleocapsids into the cytoplasm (Morgan et al., 1968). 
Immunological data supporting this theory showed that gH neutralising monoclonal 
antibodies inhibited virus entry but not attachment (Fuller and Spear 1987, Fuller et al.,
1989). Virus infectivity was restored when the neutralised virus bound to cells was treated 
with PEG, a membrane fusing compound. Other evidence supporting the fusion model 
comes from the work of Para et al. (1980) who showed that the virion glycoprotein gE was 
transferred from the virion envelope to the cell membrane in infected cells prior to DNA 
synthesis.
HSV specifies at least twelve glycoproteins, gB, gC, gD, gE, gG, gH, gl, gJ, gK, gL, gM 
and gN (Spear 1976; Marsden etal., 1978; 1984; Baucke and Spear 1979; Buckmaster et al., 
1984; Roizman et al., 1984; Spear 1985; Frame et al., 1986; Gompels and Minson, 1986, 
Longnecker et a l, 1987; Johnson and Feenstra 1987; Hutchinson et al., 1992a, b; 
Ranaswany and Holland, 1992). At least five viral glycoproteins, gB, gD, gH, gC and gL 
(Fuller et al., 1987; Ligas and Johnson, 1988; Fuller et al., 1989; Hutchinson et al., 1992a, 
1992b; Roop et al., 1993) are involved in virus entry into cultured cells. Some glycoproteins 
cross-link into homodimeric and hetero-oligomeric forms; hetero-oligomers of gB-gC, gC- 
gD, gD-gB, gH-gL, gC-gL and gD-gL have been found in purified virions (Handler, 1996), 
the best known HSV glycoprotein htero oligomer is the gE-gl interaction.
It is likely that all of the HSV glycoproteins except gK are present in the virion envelope, 
although direct evidence is lacking for gL, and gJ. Other proteins which are not glycosylated 
may also be present in the envelope e.g. the UL34 product which is a membrane-associated 
phosphoprotein (Purves et al., 1991; 1992) and the UL20 and UL34 gene products, which 
contain multiple hydrophobic domains (Baines et al., 1991; MacLean et al., 1991).
Immune EM analysis of negatively stained virus preparations revealed that gB, gC and gD 
each form distinct morphological structures projecting from the virion envelope (Stannard et 
al., 1987). Although the organisation of the envelope proteins is unknown, their structure 
and location suggest that they may play important roles in both adsorption and entry of HSV- 
1 into the host cell.
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Heparan sulphate (HS) acts as the initial receptor for both HSV-1 and HSV-2 (WuDunn and 
Spear, 1989; Lycke et a l, 1991; Shieh et a l, 1992; Shieh and Spear, 1994). Observations 
that virions bind to heparin, a related glycosaminoglycan, and that heparin blocks virus 
adsorption support this conclusion. Sawitzky e ta l, 1990 compared the effect of heparin on 
plaque formation and adsorption of PRV (strain Ka) to the effect on HSV-1 strain HFEM. 
While demonstrating that both viruses were affected by the addition of heparin they showed 
that PRV was significantly less sensitive to this treatment than HSV-1 strain HFEM. 
Enzymatic removal of heparan sulphate from the cell surface significantly reduces the binding 
of virus to cells and renders them partially resistant to infection (WuDunn and Spear, 1989). 
Binding of HSV is also severely impaired in Chinese hamster ovary (CHO) mutant cells 
defective in biosynthesis of either heparan sulphate alone or all glycosaminoglycans, or 
defective in sulphation of heparan sulphate (Shieh et a l, 1992). Virus adsorbed to cells at
4°C can be inactivated by brief exposure to low pH or soluble heparin, suggesting that HSV-
1 binds to HS with low affinity (Huang and Wagner, 1969). In addition, virus bound to the 
low affinity receptor can be neutralised by HSV-1 gD specific monoclonal antibodies 
(Highlander et al, 1987).
Glycoprotein C, a non essential protein for virion infectivity, is partly responsible for the 
interaction of virions with heparan sulphate. It is a viral structural glycoprotein with at least 
two regions that form a functional domain involved in binding to heparan sulphate (Trybala et 
al, 1994). The conclusion that gC binds to HS was based on the following findings; gC 
binds to heparin-sepharose under physiological conditions in affinity chromatography 
experiments; Herold e ta l  (1991) showed that HSV-1 mutants lacking gC exhibit significant 
impairment in adsorption and penetration; neutralising antibodies specific for HSV-1 gC are 
able to block the binding of virus to cells (Svennerholm et al, 1991; Fuller and Spear, 1985). 
Plaque-purified gC-negative syncytial mutants are more resistant than HSV-1 (KOS) to 
heparin inhibition (Pertel and Spear, 1996) due to the fact that syn mutants infect cells via cell 
to cell spread and thus avoid the need for cell surface attachment. Glycoprotein IE, the gC 
homologue of PRV is also thought to be important for the adsorption of virus to cells and, 
like HSV-1 gC, is not absolutely essential for virus infectivity (Robbins et a l, 1986; 
Schreurs et a l, 1988). The idea that gC makes the initial contact with the cell surface is 
supported by the work of Stannard et a l (1987) who showed that gC formed long slender 
structures (up to 24 nm in length) projecting from the virion envelope. It has also been 
suggested that HSV-1 strains exhibit a heparin-resistant phase of attachment, which is 
determined by gC. Lack of gC delays this heparin resistant attachment phase (Seek et a l, 
1996).
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Neomycin and polylysine aminoglycoside antibiotics have been shown to inhibit the binding 
of HSV-1 to cells to a much greater extent than HSV-2 (Langeland et al., 1987; 1988). Work 
by Oyan et al., (1993) showed that the region on the HSV genome responsible for the 
resistance to polycationic drugs maps to the amino-terminal of gC. Since gC of both HSV-1 
and HSV-2 bind to heparin, it is possible that the two serotypes may interact differently with 
cell surface HS, either having different affinities for, or binding to separate epitopes on the 
HS molecule. This hypothesis is supported by the results of Gerber et al., (1995) and 
Herold et al. (1995, 1996) who suggest that the binding of gC-2 to HS may be more similar 
to that of gB-1 than gC-1. They also suggest that the different efficiency of binding observed 
by HSV-1 and HSV-2 to different cell types is due to binding to different features of HS. 
Carboxyl reduced and 2-3, -O-desulphated heparin selectively inhibits the binding of gC 
positive viruses (wild type or gB negative) to cells, but has little or no effect on binding of a 
gC negative virus. O-desulphated heparin compounds also had little or no effect on HSV-1 
but inhibited HSV-2 infection via an interaction with gC-2.
An alternative explanation is that, in the presence of drugs which bind to HS, HSV-2 can 
interact with another cellular component via gC or another viral glycoprotein. The idea that 
HSV-1 and HSV-2 interact differently with cell surface HS was suggested by WuDunn and 
Spear (1989) who showed that HSV-1 bound to soluble heparin with much higher affinity 
than HSV-2.
Although gC is involved in adsorption of virus to cells it is not the only glycoprotein which 
can mediate this process. Kuhn et al., (1990) showed that gB, gC and gD formed complexes 
with cell membrane components during the adsorption process, confirming the results 
obtained by earlier workers who suggested roles for these glycoproteins in viral attachment 
(Fuller and Spear, 1985; Johnson et al., 1984). HSV mutants that lack gC, gB or gD can 
still attach to cells, indicating that the function of a missing glycoprotein can be replaced by 
others; this is not strictly true in the case of gD since productive infection will not occur in the 
absence of gD or gB. Evidence has been obtained suggesting that the attachment of gC 
negative virus to the cell surface HS is mediated by gB, and that this mechanism is resistant 
to neomycin and poly lysine (Herold et al., 1991). However, gB negative virions adsorb to 
cells as efficiently as wt virus (Cai et al., 1988; Herold et al., 1991). Whether the cell 
component described by Kuhn et al., (1990) that binds to gB is HS or another cellular 
component is not known. Tufaro et al., 1993 showed that cells lacking HS were susceptible 
to wt virus infection; later work (Dyer et al., 1997) showed that HSV-1 gB mediated an 
interaction with dextran sulphate a glycosaminoglycan analogue.
Following the low affinity attachment of HSV to cell surface HS, tighter binding, presumably 
via a high affinity receptor occurs, followed by penetration and internalisation; after which
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virus is resistant to acid treatment and neutralisation by monoclonal antibodies. Fuller and 
Lee (1992) speculated that the stable attachment of virus to the cell surface was necessary for 
fusion of the virion envelope with the cell membrane. Kohn (1979) proposed that high 
affinity binding involved interactions between a number of viral and cellular components. 
Evidence supporting mutivalent attachment of virus to cells comes from Rosenthal (1984) 
who demonstrated that HSV-1 binding to cells rapidly reduced cell surface protein mobility, 
similar to that caused by the multivalent attachment of other ligands such as antibodies or 
other cells. The hypothesis that more than one type of HSV attachment can occur is 
consistent with the ability of herpesviruses to bind to a wide range of cell types from diverse 
species.
Kaner et al, (1990) suggested that fibroblast growth factor receptor (bFGFR) was a portal of 
entry for HSV-1 as they found that Chinese Hamster Ovary (CHO) cells expressing a 
transfected receptor for bFGF bound and internalised greater amounts of radiolabelled HSV 
than did the bFGF deficient parental cell lines or control cells. Binding was inhibited by 
bFGF. The drawback with this study was that only one cell line - bovine arterial smooth 
muscle - was used and several groups (Shieh and Spear, 1991; Muggeridge et al, 1992) 
have since shown that inhibition by bFGF is restricted to a minority of cell types. 
Muggeridge et a l, (1992) tested several cell lines, but only one showed comparable 
inhibition by bFGF. Furthermore, they could not find a correlation between the amount of 
bFGF receptor and the ability of bFGF to block infection, as cell lines expressing low levels 
of bFGF receptor were permissive for HSV. FGF receptor positive and FGF receptor 
negative rat myoblasts do not differ in susceptibility to HSV infection (Mirda et al., 1992) 
and soluble forms of FGF fail to inhibit HSV infection whereas they inhibit basic FGF 
binding and biological activity. Taken together these results suggest that different cell types 
harbour different receptors for HSV.
Cell lines expressing gB or gC are not resistant to HSV infection and there is no evidence to 
date for saturable cell receptors for these viral proteins.
1 .4 .2
Penetration
Cell fusion is the next stage in virus entry and follows the stable attachment of virus to the 
cell surface. Studies with ts mutants, monoclonal antibody resistant mutants, syncytial 
mutants and null mutants have suggested that gB functions directly in virus entry and virus 
induced cell fusion (Sarmiento et al., 1979; Bzik et al, 1984b; Cai et al, 1988; Highlander et 
al, 1988).
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While both gD and gB have been implicated in virion induced cell fusion, it remains to be 
seen whether the attachment of these proteins to cellular membrane components is a 
prerequisite to their role in viral penetration. It is possible that gB and gD may interact with 
other viral components prior to the initiation of cell fusion.
Using biochemical and electron microscopy approaches, the entry process of HSV-1 was 
examined in detail by Fuller and Lee (1992) who observed discernible changes of the virion 
envelope and tegument after contact of infectious virus with the cell plasma membrane. 
Virions rendered non-infectious by anti-gD or anti-gH neutralising antibodies bound to cells 
but failed to form a visible fusion bridge. On the basis of these investigations, together with 
earlier findings, a model of HSV entry into cells was proposed, and this is illustrated in 
Figure 1.4.
According to the proposed model, virion attachment to cell surface HS is mediated by gC and 
to a lesser extent gB, after which, a more stable attachment of the virus to the cell occurs. 
The viral glycoprotein thought to be involved in the stable attachment of virus to cells is gD, 
since bound virions lacking gD are more sensitive to removal by heparin or high ionic 
strength washes than wt virus adsorbed to cells. Moreover, soluble gD can reduce virus 
attachment when added to cells prior to or during virus adsorption (Fuller and Lee, 1992). 
The stable attachment of the virion is believed to prime the virus for fusion with the cell 
membrane, on the basis that gD-minus and gD-neutralised viruses bind to cells but are unable 
to penetrate the cell membrane (Fuller and Spear, 1987; Highlander et al.f 1987; Ligas and 
Johnson, 1988). The model proposes that gD has two functions in viral entry. Firstly, gD 
interacts with a cellular receptor, bringing virus and cell closer together. Secondly, gD is 
believed to interact with another viral component that is directly involved in the fusion 
initiation event. The idea that gD is bifunctional comes from the observation that antibodies 
specific to gD, which prevent attachment, do not bind in the same regions as those blocking 
penetration (Eisenberg et al., 1985). Furthermore, the finding that cell surface gD interferes 
with superinfection, possibly by interacting with gD or another viral glycoprotein on the 
virion, is consistent with the hypothesis that gD interaction with another virion component 
triggers the fusion initiation event. However, it can also be argued that gD mediated 
inhibition of superinfection results from the sequestering of a cellular receptor by cell surface 
gD. This idea appears more likely and is supported by the work of Johnson et a l (1990) 
who showed that gD bound to a 170 kDa cellular membrane protein, the mannose 6- 
phosphate receptor, that is much less abundant than cell surface HS.
The first cellular mediator of HSV entry to be fully determined was herpes virus entry 
mediator (HVEM), a member of the tumour necrosis factor receptor family, later designated 
HveA (hepesvirus entry mediator A) (Montgomery et al., 1996; Whitbeck et al., 1997;
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Figure 1.4: Model of HSV-1 cell-entry as proposed by Fuller and Lee
(1992).
A. Initial attachment of virus to the cell surface.
B . Stable attachment.
C . Initiation of fusion bridge.
D. Expansion of fusion bridge.
E. Release of nucleocapsid into the cytoplasm.
Adapted from Fuller and Lee (1992).
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Marsters et al., 1997). It is thought that gD binds this receptor since mutations in gD 
determine the ability of HSV-1 to utilize HveA for entry. HveA has also been implicated in 
virus-induced cell fusion (Terry-Allison e ta l, 1998). Hve A is the principal receptor for the 
entry of HSV-1 into human lymphoid cells, but not other naturally infected cell types 
(Montgomery et a l, 1996). It does not mediate the entry of PRV or HSV-2.
A second mediator of HSV entry identified recently was designated HveB. It was identified 
as poliovirus receptor-related protein 2 , a membrane glycoprotein that is a member of the 
immunoglobulin superfamily. So far no function and no poliovirus receptor affinity have 
been reported for this protein. It mediates the entry of HSV-2, PRV and some viable HSV-1 
mutants but does not mediate the entry of wild type HSV-1 strains or BHV-1 (Warner et a l, 
1998).
HveC was also discovered recently (Geraghty et a l, 1998). It is poliovirus receptor related 
protein-1 and mediates the entry of HSV-1 and HSV-2, PRV and BHV-1. It is expressed in 
human cells of epithelial and neuronal origin making it a suitable candidate for the receptor on 
epithelial cells. Geraghty et a l (1998) also found that the poliovirus receptor (Pvr), 
designated Pvr-HveD, can mediate the entry of PRV and BHV-1 but not HSV. It is thought 
that each of these entry proteins may recognise overlapping but distinct structural domains of 
gD. It has been suggested that receptors for the herpesviruses are heterogeneously 
distributed on epithelial cells (Sears et a l, 1991). However, no quantitative evidence of 
preferential polarized uptake of wt HSV into an epithelial cell has yet been observed (Topp et 
al, 1997) and likewise, no evidence presently exists for a polarized distribution of gD 
receptors.
According to the model shown in (Fig. 1.4), the formation of a fusion bridge is the next step 
in virus entry, which may be triggered by changes in the conformation of gD due to receptor 
interaction. Similarly, formation of a fusion bridge may be mediated in part by 
conformational changes in gC or gB (or other viral components) which occur after HS 
interaction. Fuller and Lee (1992) observed visible fusion bridges for virus inactivated by 
gH specific antibodies and subsequently proposed that gH interacts either directly or 
indirectly with gD in cell fusion. Glycoprotein H, although essential for virion infectivity, 
does not appear to form complexes with any cellular component (Kuhn, 1990), and no 
distinct structures of gH have been detected on the surface of virion envelopes, suggesting 
that gH is probably not involved in virus attachment (Stannard et a l, 1987). Interaction of 
gH with the cell is thought to follow gD, since virus inactivated by gH neutralising antibodies 
appeared to be blocked at a later stage than gD inactivated virus (Fuller and Lee, 1992). Viral 
mutants that are gH negative are frozen at the gD fusion bridge stage and do not become 
internalised. Furthermore, a high multiplicity of infection (moi) of gH-negative virus bound
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to cells inhibited entry of superinfecting wt virus (Fuller and Spear, 1987; Forrester et a l,
1992), whereas gD-negative virus had little effect (Johnson and Ligas, 1988). It is possible 
that gD or gH may independently mediate virion fusion, since both are required for HSV- 
induced cell fusion (Fuller and Spear, 1987; Highlander et al., 1987; Ligas and Johnson, 
1988; Fuller et al., 1989), although the finding that neither gD or gH alone can mediate 
substantial fusion of most cells, supports the idea that gH and gD and perhaps other viral 
glycoproteins (i.e. gB and gK) act synergisically to mediate HSV fusion (Campadelli-Fiume 
eta l, 1988b; Butcher et al, 1990; Peeters eta l, 1992 a, b). This proposal is supported by 
reports which show that most or all of the gH in infected cells is complexed with gL and that 
the correct processing and intracellular transport of gH in infected cells, is dependent on the 
coexpression of gL (Hutchinson et al, 1992a).
The model also proposes that during initiation of the fusion bridge, rearrangement of the 
virion envelope and tegument proteins occur (Fig. 1.4), allowing the nucleocapsid to be 
positioned towards the cell.
The final stage of viral entry, involves the expansion of the fusion bridge and the subsequent 
release of the nucleocapsid into the cytoplasm (Fig. 1.4). It is likely that gB has an essential 
role in virus induced cell fusion, since gB-null syncytial virus can cause complete fusion of 
gB-transformed cell lines, but no fusion of untransformed cells (Cai et a l, 1988). 
Furthermore, the glycoproteins gK and gL, in addition to other viral components, may play 
important roles in mediating and controlling the changes observed in the virion particle or cell 
membrane and subsequent release of the nucleocapsid into the cytoplasm (Hutchinson et al, 
1992b; Ramaswamy and Holland, 1992).
The role of non-glycosylated proteins in viral attachment and fusion has not been thoroughly 
addressed. Previous investigations showed that virus attachment can occur when 
glycosylation is inhibited, suggesting that other viral proteins may be important in virus 
binding (Svennerholm et a l, 1982; Kuhn etal., 1988). Spivack et al., (1982) found that 
unglycosylated virus was capable of attaching to Vero cells almost as well as control virus, 
with only a slight decrease in levels of attachment, The rate of adsorption of both viruses was 
similar. An alternative explanation is that glycosylation is not required for the interaction of 
viral attachment proteins to the cell receptors. Campadelli-Fiume et a l, 1982 reported that the 
infectivity of HSV-1 does not require the mature form of glycoproteins, but that the precursor 
forms will suffice.
All this indicates that HSV-1 entry into cells is mediated by a cascade of virus-cell interactions 
in which each glycoprotein plays a specific role in triggering or signalling changes in the 
virion which result in membrane fusion and nucleocapsid uncoating.
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1 .4 .3
Cell-to-cell spread.
It is difficult to understand how the glycoproteins are involved in cell to cell spread since 
many different reports exist that are conflicting or ambiguous.
The process of cell to cell spread is different from that of cell-virion fusion, and even though 
these processes share some aspects they are not analogous. Glycoproteins H, L, D and B are 
required both for virion entry and cell to cell spread, whereas gE, gl and gM are only 
required for cell to cell spread. Glycoproteins G and J are not essential for either process. 
This difference in requirement may be due to the difference between the types of membrane 
involved. Plasma membranes and virion envelopes differ in their lipid and cholesterol 
composition, as well as in their degree of curvature. It is also thought that the concentration 
of HS V glycoproteins present in the two membranes are different.
To date four viral genes UL53 (gK) (Debroy et a l, 1985; Pogue-Geile and Spear, 1987), 
UL27 (gB) (Kousoulas et al., 1984; Bzik et al., 1984 a), UL24 (Sanders et al., 1982; 
Jacobson et al., 1989), and UL20 (Baines et al., 1991) have been associated with the 
syncytial phenotype. A fifth syncytial locus has been suggested to map within the inverted 
repeats flanking U l  although the gene product involved has not yet been identified 
(Romanelli etal., 1991).
1 .4 .4
Virulence.
Since HSV-1 glycoproteins play an important role in the early stages of the virus life cycle in 
vitro (adsorption and penetration) it is expected that they are also relevant in vivo. It was 
believed that gC had no role as a virulence determinant in the mouse model as gC negative 
mutants of both HSV-1 and HSV-2 remained highly virulent following intravaginal (Johnson 
etal., 1986), intracerebral and footpad inoculation (Dix et al., 1983; Sunstrum et al., 1988). 
However, Lubinski e ta l . (1998) demonstrated that gC is a virulence factor when examined 
in their guinea pig model. These workers claim that in previous studies the virus did not 
actually encounter complement in vivo. They showed that in C3 deficient guinea pigs gC 
negative viruses reached significantly higher titres than in complement intact animals 
behaving similarly to wild type or rescued virus. They concluded that gC has a 10-100 fold 
effect on virulence, while wild type virus has a near-total protection against complement 
conferred by gC.
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Monoclonal resistant (mar-) gB or gD mutants have no significant alteration in pathogenicity 
(Kumel et al, 1985). Meignier et a l (1988) demonstrated that a gE negative mutant was not 
significantly impaired in neurovirulence following intracranial inoculation of mice, with a 
LD50 less than 100 fold higher than that of the parental virus.
Both HSV-1 Ang and HSV-1 KOS are completely non-neurovirulent following inoculation 
on the mouse footpad (Kumel et a l, 1983; Kaemer et a l, 1983; Thompson et al, 1986) 
although both are neurovirulent following intracerebral inoculation. Following passage in the 
mouse brain, variants of HSV-1 Ang arise (Ang path) which are capable of causing lethal 
neurological disease following footpad inoculation. This increase in neurovirulence (as 
defined by the ability of the virus to spread to the CNS following peripheral inoculation) is 
associated with a single base change in the gD ORF (Izumi and Stevens, 1990). In HSV-1 
KOS, two loci are required for complete restoration of a neuroinvasive phenotype (Yuhaz and 
Stevens, 1993): one within a region of the genome encoding the genes UL10, UL11, UL12, 
UL13 and parts of UL9 and UL15 has not yet been fully characterised, whereas the other is 
localised to gB; as with HSV-1 Ang, a single base pair change in a glycoprotein greatly 
affects neuroinvasineness. gB and gD play a role in virus adsorption and penetration, and 
thus the decrease in neuroinvasiveness associated with these amino acid substitutions may be 
due to a decreased affinity of the mutant glycoproteins for their cellular receptors, leading to 
less efficient spread in the nervous system.
Two amino acid substitutions in the C-terminal region of gB have been shown to produce a 
virus which is still virulent following footpad inoculation but produces unusual clinical 
symptoms (Goodman and Engel, 1991; Engel eta l, 1993). Unlike inoculation with the wild 
type virus, HSV-1 strain 17+, an acute inflammatory response occurs in inoculated footpads 
with subsequent death of the inoculated animal without hindlimb paralysis. This is possibly 
due to the alterations in gB affecting antigen presentation, and thus affecting the host 
response to infection.
1 .4 .5
Fc receptor.
Receptors which have affinity for the Fc domain of immunoglobulin G (IgG) are expressed 
on the surfaces of cells infected with a number of human herpesviruses (Johnson et al, 
1988). HSV-1 infected cells and the virion envelope express such receptors (McTaggart et 
al,. 1978; Westmoreland and Watkins, 1974). A group of electrophoretically similar HSV-1 
polypeptides that bound IgG columns with high affinity were identified by Bauke and Spear 
(1979). They were thought to be derived by post-translational modification of gE (Cross et
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al., 1987). However, Johnson and Feenestra (1987) subsequently discovered a novel HSV- 
1 induced polypeptide that was structurally distinct from gE and was provisionally named 
gp70. This polypeptide could be detected on the surfaces of infected cells and was co­
precipitated using rabbit or human IgG or anti-gE antibodies. It was later mapped to the US7 
open reading frame and named gl (Johnson et al, 1988; McGeoch et al., 1988a). The gE-gl 
hetero-oligomer also facilitates cell-to-cell spread of virus in epithelial and neuronal cells 
(Dingwell et al., 1995).
Expression of gE alone is sufficient for induction of Fc activity, while gl alone produces no 
detectable binding (Bell et al., 1990; Dublin et al., 1990). Coexpression of gl and gE gives 
better binding than expression of gE alone, suggesting that HSV-1 has the potential to induce 
two Fc receptors - one a low affinity receptor composed of gE alone, and a second high 
affinity receptor composed of gE and gl. gE appears to be the Fc receptor for complexed 
IgG, while gE and gl form the Fc receptor for monomeric IgG (Dublin et al., 1990; Basu et 
al., 1997).
It is not clear what physiological role these Fc receptors play in the replicative cycles of 
herpesviruses since studies to define their biological relevance have been hampered by the 
fact that gE null mutants are severely attenuated in vivo due to the defect in cell to cell spread. 
However it has been suggested that they influence events in the infected cell or act to reduce 
immune cytolysis of virus-infected cells. Fc receptors may function by coating the virus 
infected cells with IgG so as to reduce exposure of viral antigens to immune effector cells, or 
they may bind oligopeptides that share some structural homology with immunoglobulin Fc 
receptors, e.g. histocompatability antigens (Johnson et al., 1988).
The domain of gE involved in IgG binding is however distinct from the domain involved in 
mediating cell-to-cell spread (Weeks et al., 1997). Nagashunmugan et al., (1998) 
constructed a mutant virus that was only altered at a small region within the gE IgG Fc 
binding domain and thus conserved other functions mediated by gE. This mutant displayed a 
significant reduction in its ability to cause disease and was highly sensitive to human anti- 
HSV IgG.
1 .4 .6
C3b binding.
HSV-1 infected mammalian cells express receptors for the C3b component of complement in 
culture (Cines etal., 1982). These receptors are not present following HSV-2 infection. It 
has been shown that gC-1 but not gC-2 functions as a C3b receptor when expressed on cells 
(Friedman et al., 1984). There is a 28 amino acid insert in gC-1 compared to gC-2 (Frink et
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al, 1983; Swain et al., 1985) that may explain the functional differences between the two 
glycoproteins.
Kostavasil et al., (1997) used a baculovirus expression system to show that both gC-1 and 
gC-2 bind C3, C3b and C3c, but not to C3d. This suggests that: 1) the binding sites for 
these proteins are found in the C3c region of C3 and 2) that gC, in contrast to the other C3- 
binding proteins, interacts with native C3.
gC-1 but not gC-2 inhibits the binding of C5 and properdin to C3b and also inhibits the 
alternative pathway-mediated lysis of rabbit erythrocytes (Kostavasil et al., 1997; Hung et 
al., 1994). Inhibition of alternative pathway-mediated lysis and properdin binding to C3b, 
but not of C5 binding to C3b, requires the transmembrane segment of gC-1. These roles of 
gC inhibit activation of the complement cascade thus protecting HSV-1 from complement 
mediated neutralisation (Gerber et al., 1995; Hidaka et a l, 1991). There may also be a strain 
dependent effect on the level of binding with HSV-1 strain KOS exhibiting much less C3b 
binding than most other HSV-1 isolates (Freidman etal., 1986).
gC-1 demonstrates dose-dependent acceleration of decay in the activity of C3 convertase of 
the alternative pathway, and can block the effects of complement via this mechanism (Fries et 
al., 1986). Thus gC-1 can protect against complement mediated cytolysis (Harris et al.,
1990) by inhibition of the alternative pathway. In the absence of gC-1, complement 
neutralisation is rapid and is mediated by components of the classical complement pathway 
(Friedman et al., 1995). Glycoprotein C mainly protects against antibody-independent 
complement neutralisation, suggesting that it has a role early in infection, before antibodies 
develop. Friedman et al. (1986) observe that once antibody binds to gC it alters the ability of 
this glycoprotein to interact with C3b. Thus appears that once the host develops an antibody 
response the C3b binding will be reduced and thus the selective advantage offered by the 
presence of gC is only valid before anti-gC antibody is made.
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2. Materials.
2.1
Cell culture media.
Eagle's medium (Gibco), supplemented with 10% new-born calf serum (Gibco), 100 |ig/ml 
streptomycin (Gibco), 100 units/ml penicillin and tryptose phosphate. This is subsequently 
referred to as ETC 10.
A variation on this basic growth media was:
EMC 10 Eagles medium containing 1% carboxymethylcellulose and 10% new-born calf 
serum.
Dulbecco's Modified Eagle's medium (Gibco) supplemented with 10% foetal calf serum 
(Gibco), 200mM glutamine (Gibco), 100 jLig/ml streptomycin (Gibco) 100 units/ml penicillin 
was used for the growth of HeLa, 3T6, Vero and C6 glioma cells. This is subsequently 
referred to as DMEM10.
2.2
Cells.
BHK21/C13 (Mcpherson and Stoker, 1962), C6 gliomal cells (Hill, 1968), HeLa (Griffiths, 
1953), 3T6 (Harris and Sutherland, 1965) and Vero Thornton, 1963).
2 .3
Viruses.
The wild type HSV-1 strains used in this study were HSV-1 strain 17+ (Brown e ta l, 1973), 
HSV-1 strain F (Ejercito et a l, 1968), HSV-1 SC16 (Hill et a l, 1975) and HSV-1 HFEM 
(Halliburton et al, 1980).
The gC- mutants of these viruses were designated strain 17 gC negative, R6012, SC 16-
AUL44-Z and HFEM-AUL44-Z respectively. (Cunningham and Davison 1993; Sears et a l,
1991; Griffiths et al, 1998). Both the SC16 mutant and the HFEM mutant contained lac Z 
expression cassettes in the UL44 gene (Fig. 3.3).
HSV-1 strain 17 wild type and gC negative lac Z expressing viruses (with lacZ in the UL43 
locus) were called 17+ lacZ and 17gC negative lacZ. (Figure 3.2).
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2 .4
(3-galactosidase stain.
PBS A containing 5mM K4Fe(CN)6, 5mM K3Fe(CN)6.3H20 , 2mM MgCl2, lmg/ml X-gal. 
X-gal was dissolved in dimethyl formamide (DMF) at a concentration of 20mg/ml and added 
just before use.
2 .5
Antibodies.
Mouse monoclonal antibodies against gC were supplied by Dr. Anne Cross, Institute of 
Virology, and used at a dilution of 1/1000.
2.6
Enzymes.
Restriction enzymes were supplied by Boehringer Mannheim or New England Biolabs and 
used in the appropriate manufacturer's buffer
2 .7
Radioisotopes.
32P dCTP was supplied by New England Biolabs.
2.8
Chemicals.
The chemicals used were of analytical grade and were supplied by either BDH Chemicals, 
UK, or Sigma Chemical Co. Exceptions were:
APS and TEMED 
Boric acid and glycerol 
Ficoll
Gluteraldehyde 
Proteinase K
Bio-Rad Laboratories 
PROLAB
Pharmacia, Upsalla, Sweden 
Agar Aids, Cambridge, England 
Boehringer Mannheim, Germany
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2 .9
Commonly used buffers
Alkaline lysis solution I
Alkaline lysis solution II 
Alkaline lysis solution El 
Chloroform:isoamylalcohol 
Gel soak I 
Gel soak II
Hybridization buffer 
Phenol chloroform (1:1)
PBS -A
PBS complete 
PBS /calf serum 
RE stop
Saturated phenol
ssc
TBE
Trypsin
Trypsin-Versene
Versene
X-gal
and solutions.
lOmM EDTA, 50mM glucose, 25mM 
Tris-Cl pH 8.0 and 5mg/ml lysozyme added 
prior to use.
200mM NaOH, l%(w/v)SDS.
5M potassium acetate, pH4.8.
24:1 mixture of chloroform and isoamylalcohol 
600mM NaCl, 200mM NaOH.
600mM NaCl, 1M Tris-HCl, adjusted to pH8.0 with 
HC1.
7% SDS, 0.5M NaP04 (NaH2P 0 4; N a ^ P O ^ p ^ ^  
1:1 mixture of phenol and chloroform.
170mM NaCl, 3.4mM KC1, lOmM Na2HP04,
1.8mM KH2PO4 , pH7.2.
PBS A plus 6 .8mM CaCl2, 4.9mM MgCl2.
PBS complete containing 5% newborn calf serum. 
lOOmM EDTA, 10% (w/v) Ficoll 400,0.25% (w/v) 
bromophenol blue, 5x TBE.
Phenol saturated by mixing 1:1 with phenol saturation 
buffer, (lOmM Tris-HCl, pH7.5, lOmM EDTA, 
lOOmM NaCl).
153mM trisodium citrate, 150mM NaCl.
2mM EDTA, 89mM boric acid, 89mM Tris-HCl 
pH8.0.
0.25% (w/v) Difco trypsin dissolved in Tris-saline.
1 volume trypsin and 4 volumes versene.
0.6mM EDTA dissolved in PBS containing 0.002% 
(w/v) phenol red.
20mg/ml in dimethylformamide.
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Miscellaneous.
Hybond™_ N hybridization transfer membranes 
Hybond™_ECL hybridization transfer membranes 
Giemsa stain 
XS-1 film
Chapter 2: Materials
Amersham
Amersham
BDH
Kodak
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3. Methods.
3.1
Growth of cells
BHK21/C13 cells were grown in 80oz roller bottles containing 100ml ETC 10 medium at 
37°C for 3 days in an atmosphere of 95% air and 5% C 02 (MacPherson and Stoker, 1962). 
This gave a yield of approximately 1x10s cells per bottle. Confluent cells were harvested by 
washing the monolayers twice with 25ml of trypsin-versene, and resuspending the detached 
cells in 20ml of ETC10. Cells from one bottle could then be split 1/10 to seed a further ten 
roller bottles.
The 3T6, HeLa, Vero and C6 cells were grown in flasks in DMEM and harvested as 
described above, with a split of 1/4.
For some experiments cells were plated on 60mm or 30mm petri dishes or Linbro wells at a 
density of 4xl06, 2xl06 and 5x10s cells per plate respectively.
3.2
Preparation of virus stock.
Virus stocks were prepared as described by Brown et a l . (1973). Confluent roller bottles of 
BHK21/C13 cells were infected with 0.001 p.f.u./cell (assuming 1 x 108 cells/bottle) of HSV
in 20ml of ETC10 and incubated at 31°C for 3-4 days, until c.p.e. was complete, when the 
cells were shaken into the medium. The cells were pelleted in 250ml plastic falcon tubes by 
spinning at 2K for 10 minutes at 4°C in a Fison's Coolspin. The supernatant and cell pellet 
were separated and two individual vims stocks prepared:
Supernatant stock: The supernatant was poured into 250ml centrifuge bottles and spun at
12K for 2h (4°C) in a Sorvall GSA rotor. The supernatant was discarded, and the vims
pellet resuspended in 1ml ETC10 or PBS/calf semm per roller bottle. The pellet was
sonicated until homogeneous, before aliquoting into 1ml amounts and storing at -70°C.
Cell-associated stock: The cell pellet was resuspended in 0.5ml medium/ roller bottle and 
thoroughly sonicated before spinning at 2K for 10 minutes at 4°C in a Fison's Coolspin 
centrifuge. The supernatant was kept on ice while the process was repeated. The two 
supernatants were combined to give the cell-associated vims stock. This was aliquoted and 
stored as above.
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3 .3
Titration of virus stocks
Virus stocks were serially diluted 10-fold in PBS/calf serum. IOOjliI aliquots were added to 
75% confluent monolayers of BHK21/C13 cells on 60mm petri dishes from which the 
medium had been removed. The plates were incubated at 37°C for 45min-lh, to allow 
adsorption of the virus to the cells, before overlaying with 5ml EMC 10%. Plates were
incubated at 37°C for 2 days or 31°C for three days. Monolayers were fixed and stained
with Giemsa at RT. After washing, plaques were counted on a dissecting microscope and 
virus titres calculated as p.f.u./ml.
3 .4
Sterility checks on virus stocks.
Brain heart infusion agar (BHI) plates and BHI plates containing 10% horse blood (BHI 
blood agar) were obtained from the Cytology department.
To check for fungal contamination of stocks, a small aliquot was streaked onto BHI plates in 
duplicate and the plates sealed with parafilm and incubated at RT. Bacterial contamination
was detected by plating onto blood agar and incubating at 37°C. If no colonies were visible
after 7 days incubation, the stocks were considered sterile.
3.5
Growth, labelling and purification of HSV-1 Virions.
Virions were labelled and purified essentially by the method of Szilagyi & Cunningham 
(1991). Monolayers of BHK21/C13 cells in roller bottles were infected with HSV-1 at a moi 
of 0.01 p.f.u/cell and incubated at 31°C for 3 days. To label the virion proteins, monolayers 
were infected with HSV-1 at a moi of 5 p.f.u/cell in medium containing one-fifth the normal
amount of methionine/2% calf serum and incubated at 37°C for 4 h, 25uCi/ml of 35S- 
methionine added and labelled for 16-20 h at 37°C. Once the c.p.e. was complete the 
supernatant was removed and cell debris pelleted by low speed centrifugation (l,000g for 10 
min at 4°C). Virus particles from the clarified medium were pelleted by centrifugation at 
23,000 g for 2 h at 4°C. The pellet was gently resuspended in 1 ml of modified medium 
(culture medium without phenol red or calf serum) and layered onto a 35-ml preformed 
gradient of 5 to 15% ficoll 400 suspended in this medium. After centrifugation in a swing- 
out rotor (26,000g for 2 h at 4°C in an AH629 cellulose nitrate tube), the virion bands were
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withdrawn by puncturing the tube with a broad needle. These virions were diluted and 
pelleted by centrifugation (21,000 r.p.m. for 2 h at 4°C in an AH269 tube). The virion pellet
was gently resusupended in lOOpl of modified medium and either used immediately or stored
at -70°C.
3 .6
Purification of |3-galactosidase expressing viruses.
Serial 10 fold dilutions of virus were prepared and lOOjil of each dilution used to infect a 
BHK21/C13 monolayer in a 35mm diameter tissue culture dish. After adsorption for lhr the 
inocula were removed, the cells overlaid with 3ml of EMC 10 per dish and incubated at 37°C 
until plaques were visible under a low magnification. The overlay was removed and replaced 
with an X-gal overlay (EMC10 with lOOjig/ml X-gal) and incubated at 37°C until blue 
plaques were visible.
Blue plaques were isolated in a volume of 20pl with a micropipette, transferred to 1ml
PBS/calf serum, bath sonicated and subjected to plaque purifications until 100% of plaques 
were stained blue by the X-gal overlay.
Plaque isolates were screened by Southern blotting to ensure the correct DNA structure at the 
region of modification.
3 .7
Assay for rate of virus adsorption
Monolayers of cells (4xl06) in 50 mm petri dishes were precooled for 1 hr at 4°C and 
inoculated with virus at a multiplicity of infection (m.o.i.) of 300 p.f.u/plate and left at 4°C 
for various lengths of time up to 4 hr. At each timepoint, the appropriate plates were washed 
three times with PBS/calf serum and overlaid with EMC 10. The plates were incubated at 
37°C for 2 days after which time they were fixed and stained. Plaques were counted, and the 
% of vims adsorbed at each time-point determined, relative to the final timepoint (4 hr) which 
represented 100% adsorption. Each timepoint was performed in triplicate.
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3.8
Assay for rate of virus penetration
Virus penetration was assessed by determining the rate at which adsorbed virus became 
resistant to inactivation by a low-pH citrate buffer. The method used was essentially as 
described by Huang and Wagner (1964) and Highlander et al., (1987). Confluent
BHK21/C13 cells (4xl06) in 50 mm petri dishes were separately infected with 300 p.f.u per 
plate of either wild-type or mutant virus and allowed to adsorb for 2h at 4°C. The unbound 
virus was removed by washing four times with PBS and the cells overlaid with Eagle’s 
medium and moved to 37°C to allow viral penetration to proceed. At selected timepoints after 
the temperature shift, plates were either treated with 1 ml of citrate buffer (40 mM citric acid, 
lOmM KC1, 135mM N aCl, pH 3.0) or 1 ml of PBS for 5 min as a control. The monolayers 
were washed three times with PBS overlaid with EMC 10 and incubated at 37°C for 2 days. 
The plaques were visualised with Giemsa stain and counted. Each timepoint was performed 
in triplicate. The amount of penetrated virus at each timepoint was expressed as % of p.f.u 
on the citrate buffer treated plate compared to PBS control.
3.9
Heparin inhibition.
Three hundred p.f.u of virus were adsorbed to 100% confluent BHK21/C13 monolayers at
4°C for 3hr in the presence of increasing concentrations of heparin. The inoculum was
removed, and the monolayers washed three times with PBS/calf serum before overlaying
with EMC 10 and incubating at 37°C for 2 days. The number of plaques was counted and
expressed as a % of the value obtained with no heparin. The experiment was performed in 
triplicate with each heparin concentration.
3.10
Staining of tissue culture monolayers for p-galactosidase.
The medium was removed from cell monolayers in tissue culture dishes and the cells washed 
with PBS A. The cells were fixed by overlaying with PBS A/Gluteraldehyde/Formaldehyde 
and incubated at RT for 15 minutes. This solution was removed, and after two washes with
PBS-A, 1ml p-galactosidase stain was added and the monolayer incubated at 37°C until blue
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foci were visible. The p-galactosidase stain was removed, the monolayer washed with 
distilled water and blue foci counted under a dissection microscope.
3.11
Binding of radioactive virions.
Monolayers of BHK21/C13 cells (4xl06) in 50mm petri dishes were precooled for lhr at 4°C
and inoculated with radioactively labelled Ficoll banded virus at a moi of 5xl02 particles/cell, 
and left for various lengths of time up to 4hr. At various timepoints, the inoculum was
removed and placed in a scintillation vial. The cells were then lysed with lOOjXl 2.5% (w/v)
SDS for at least 10 minutes at RT and the lysate transferred to a fresh scintillation vial. The 
radioactivity was counted and the percentage of virus bound at each timepoint calculated 
relative to the total counts (bound and unbound).
3.12
In vivo studies of latency.
As described by Clements and Subak-Sharpe (1983, 1988), 4 week old Balb/C mice were
inoculated in the right rear footpad with various doses of virus in 25(il PBS/calf serum. After
six weeks, all surviving mice were killed, dissected and the ten ipsilateral dorsal root ganglia 
supplying the lower limb of each mouse were separately cultured in microtitre plates. They 
were screened every second day for the presence of infectious virus by transferring the 
culture supernatant to control BHK21/C13 cells which were incubated for two days at 37°C, 
before staining and examination for the presence of virus plaques or cpe. Results were 
expressed as the percentage of the total ganglia reactivating each day.
3.13
Pathogenicity.
Three week old Balb/C mice were anaesthatiSed and 0.025ml of the appropriate virus dilution 
in PBS/calf serum injected into the central region of the left cerebral hemisphere. Groups of 
6 or 7 mice were inoculated with a single dilution of each virus stock (between 101 and 104 
p.f.u/animal). Mice were observed daily for 21 days after inoculation and their clinical states
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recorded. The 50% lethal dose value (LD50) was calculated according to the formula of Reed 
and Muench (1938).
3.14
Phenol-chloroform extraction of DNA.
If the digestion mixture was less than lOOpl, it was increased to this volume using dH2 0 .
An equal volume of phenol:chloroform was added, the mixture shaken vigorously, and spun 
at 13000g for 2 minutes in a microfuge. The top aqueous layer was transferred to a separate 
eppendorf tube and the bottom layer back extracted with an equal volume of dH2 0 . An equal
volume of chloroform was added to the aqueous layer and the mixture mixed and spun at 
13000g for 2 minutes in a microfuge. The top layer was removed and the sample back 
extracted as before.
To precipitate the DNA, 2 volumes of ethanol and 0.1 volumes of 3M sodium acetate were 
added. Following 10 minutes incubation on dry ice, the DNA was pelleted at 13000g for 5 
minutes, washed with 70% ethanol and dried in a vacuum desiccator, before resuspending in 
an appropriate volume of dH2 0 .
3.15
Preparation of small amounts of virus infected cell DNA for Southern 
blotting
BHK21/C13 cell monolayers (5x105 cells) on 24 well linbro trays were infected at a moi of 5 
p.f.u/cell at 37 °C. After 48 h the supernatant was removed and the cells lysed by incubating 
with 750ul of lysis buffer (0.6% (w/v) SDS,10mM EDTA, lOmM Tris.HCl pH 7.4)
containing 500pg/ml protease, for a minimum of 4 h at 37°C. Infected cell DNA was
extracted twice with an equal volume of phenol and once with chloroform, precipitated by the 
addition of 2 volumes of ethanol and dried in a vacuum desiccator. The DNA was dissolved
in 200ul of water containing 50pg/ml RNase A. Restriction enzyme digestions were usually 
carried out on 5% of the total sample (lOpl).,
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3 .1 6
Restriction enzyme digestion of DNA
The manufacturer's recommended buffers and conditions were generally used for each
individual restriction enzyme. To achieve complete digestion, ljig samples of HSV or
plasmid DNA were digested with 2-5 units of restriction enzyme for 4h at the appropriate 
temperature. If the digested DNA was to be run on an agarose gel, 1/5- 1/6 volume of RE 
stop was added prior to loading, otherwise the digested DNA was recovered as described in 
section 3.14.
3 .1 7
Agarose gel electrophoresis.
Restriction endonuclease digestions of viral or plasmid DNA were analysed on 0.4-1.5% 
(w/v) agarose gels. Agarose was boiled in 200ml lxTBE buffer. When cool, ethidium
bromide was added to the agarose solution to a final concentration of 0.5|Xg/ml before
pouring the solutions onto glass plates (16.5x26.5cm) whose edges had been sealed with gel 
tape and onto which 12-26 tooth combs had been placed. The gels were allowed to set at RT 
and transferred to horizontal tanks containing lxTBE buffer. DNA samples were mixed- 
with one-fifth volume of RE stop, loaded into the gel tracks and electrophoresed at 40-120V 
for 4-16h (Sambrook et a l ., 1989).
3 .1 8
Southern blotting.
Purified virus or infected cell DNA was digested with the appropriate restriction enzyme(s) 
before running on an agarose gel. The gel was visualised under short wave UV light to 
confirm DNA digestion and to partially fragment larger DNA fragments and so aid their 
transfer to membranes.
The gel was placed in 500ml Gel Soak I (see section 2.19) for lhr, rinsed with deionised 
water and transferred to Gel Soak II for lhr. After rinsing as before, it was transferred to 
500ml lOxSSC for a further lhr. The gel was then ready for blotting onto either one or two 
sheets simultaneously of Hybond N nylon itiembrane (Amersham). For each transfer one 
sheet of nylon membrane and five sheets of Whatmann 3MM paper, cut to the gel size, were 
required.
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A pile of "Hi-Dry" towels was placed on the bench and topped by three sheets of dry 3MM 
filter paper, followed by two sheets soaked in lOxSSC. The nylon membrane, which had 
also been soaked in lOxSSC was placed on top of the filter paper followed by the gel, 
ensuring that there were no air bubbles between the gel and the nylon membrane. A glass 
plate and heavy weight were placed on top and left overnight, during which time the DNA 
was drawn out of the gel onto the adjacent side of the nitrocellulose. To transfer DNA to two 
membranes this procedure was repeated in reverse on top of the gel.
The DNA was cross linked to the nylon membrane using a UV Stratalinker, and hybridized to 
the labelled probe in a sealed bag containing 20ml hybridization buffer overnight at 65°C.
The nylon membrane was washed twice for 30 minutes with 1 litre 2xSSC, 0.1% (w/v) SDS 
before drying and setting up for autoradiography against Kodak XS-1 film.
3.19
Western blotting.
SDS-PAGE was carried out using slab gels cast vertically in a sandwich consisting of two 
glass plates separated by 1.5mm perspex spacers. A 60ml gel mix was prepared using a 
running gel buffer (RGB) which contained 375mM Tris-Cl, pH 8.9 and 0.1%(w/v) SDS. 
Polymerisation was achieved by the addition of 0.006% (w/v) ammonium persulphate 
(APS), and 0.004% (v/v) N,N,N',N', tetramethylenediamine (TEMED), just prior to 
pouring. A thin layer of butan-2-ol (3.5ml), was poured on top to exclude air and produce a 
level surface. Prior to adding the stacking gel, the butan-2-ol was removed and the surface of 
the running gel rinsed with distilled water.
The stacking gel was composed of 5% acrylamide, crosslinked with the same ratio of N,N'- 
methylenebisacrylamide used in the resolving gel, in stacking gel buffer (SGB), composed of 
0.11M Tris HC1, pH 6.7 and 0.1% (w/v) SDS. APS and TEMED were added to the gel just 
before pouring and a Teflon comb was used to form the wells.
Infected cell proteins were harvested into boiling mix (50mM Tris Cl pH6.7, 2% SDS, 
700mM 2-mercaptoethanol, 10% glycerol, bromophenol blue). Samples were boiled for five 
minutes before loading on the gel, and run overnight at 8mA. Once separated, the proteins 
were transferred onto nitrocellulose using a Bio-Rad Transblot apparatus. The foam pads, 
sheets of Whatmann 3MM paper and the nitrocellulose used for the transfer were pre-soaked 
in transfer buffer (192mM glycine, 25 mM Tris.HCl pH8.3, 20% methanol). The gel was 
placed on top of the nitrocellulose, three sheets of 3MM paper and a foam pad. Three more 
sheets of 3MM paper and another foam pad were placed on top and the gel sandwich was 
held together in a plastic folder that was closed and placed in the transfer kit, ensuring that the
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gel was towards the cathode and the nitrocellolose to the anode. Transfer took place for a 
minimum of three hours at 250mA and when complete the nitrocellulose was removed, 
placed in a plastic tub and blocked by washing twice for 30 minutes using 2% dried milk in 
PBS, 0.05% Tween 20 (PBST). The nitrocellulose was then washed for 10 minutes three 
times in PBST, before addition of the primary antibody diluted appropriately in PBST, 1% 
BSA and incubated for 2 hr at 37°C or overnight at 4°C or RT. The appropriate second 
antibody was added as a horseradish peroxidase (HRP) conjugate at a 1/1000 dilution in 
PBST, 1% BSA and incubated at 37° for 1 hr, the nitrocellulose was washed three times in 
PBS. 0.05% Tween 20. Bound antibodies were detected using the ECL system 
(Amersham). The nitrocellulose was incubated with equal volumes of reagents 1 and 2 for 
one minute at RT. The detection reagents were drained off and the nitrocellulose sheet 
covered in cling film before exposure to film for between 5 seconds and 60 minutes.
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4. Results.
4.1
Aims and background.
The entry of HS V into cells requires a cascade of events to occur at the cell surface; these can 
be divided into two distinct phases: adsorption and penetration (see sections 1.4.1 and 
1.4.2).
The adsorption of HSV-1 to host cells in culture is mainly dependent on cell surface heparan 
sulphate or related glycosaminoglycans. Heparan sulphate is a ubiquitous 
glycosaminoglycan found on proteoglycans in cell plasma membranes, extracellular matrices 
and basement membranes. It is structurally and chemically similar to heparin, although 
heparin is more highly sulphated. Although glycoprotein C (gC) of HSV-1 and its 
homologues in other alphaherpesviruses is dispensable for infectivity it is thought to play an 
important role in the initial adsorption of the virus to the host cell, because (1) gC is a heparin 
binding protein, (2) anti-gC antibodies inhibit the binding of virions to cells and (3) virions 
which lack gC bind to cells with a reduced efficiency (Fuller and Spear, 1985).
Glycoprotein B also binds to heparin and virions lacking both gC and gB bind cells with 
lower efficiency than virions lacking gC alone (Herold et a l 1994; Laquerre et al, 1998). 
This data led to the proposal that the weak binding activity of gB mediates the initial 
interaction of HSV-1 virions with cell surface glycosaminoglycans when gC is absent. The 
idea of gC as the main agent in the primary adsorption mechanism is supported by studies on 
PRV and BHV-1. The gC homologues of these viruses are heparin binding proteins and 
mutants lacking gC bind to cells with reduced efficiency.
This initial and dispensable binding of HSV-1 gC to cell surface glycans is thought to be 
followed by a stable, non-dispensable binding reaction involving other viral membrane 
proteins. Glycoprotein D is the most likely candidate as soluble gD will block infection 
(Johnson 1990), while gD negative virions fail to block infection by superinfecting virus 
(Johnson and Ligas, 1988) and several gD receptors have recently been identified in different 
cell types.
These findings led to the consensus view that the binding of alphaherpesviruses to host cells 
is achieved by the initial interaction of gC and gB with cell surface proteoglycans, followed 
by a stable binding of gD to saturable receptors. Penetration is thought to be mediated by gB 
and the gH:gL heterodimer. It appears that other glycoproteins play no significant or 
essential role in this process: virions lacking several non-essential glycoproteins show normal
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particle:p.f.u ratios (Balan e ta l, 1994) and the expression of gD, gB and gH:gL in infected 
cells is sufficient to induce cell-cell fusion (Turner et al., 1998). See section 1.4.2
The initial aim of this project was to alter the binding of HSV-1 to different cell types through 
the deletion of gC and the heparan sulphate binding region of gB. Deletions of these binding 
regions should decrease the binding of virus to cells and allow for the insertion of targeting 
molecules to specify and alter the cell types infected. Published data at the time indicated that 
there should be a difference in cell entry between wild type virus and gC' virus. The results 
obtained during my study did not correlate with this and as a result of this observation the 
project moved to look at the role of gC in various strains of HSV-1 in a range of different cell 
lines.
Due to the large numbers of figures they are presented in appendix I.
4 .2
Viruses.
Wild type HSV-1 strain 17 (Brown etal., 1973) was used, along with a gC negative mutant 
constructed by Cunningham and Davison (1993). The mutant contains a stop codon in the 
gC (UL44) ORF (Fig. 1), which results in expression of a truncated form of gC lacking the 
membrane spanning domain and therefore produces virions devoid of gC. LacZ expressing 
forms of these viruses, HSV-1 strain 17 lacZ and gC negative lacZ, were also used. The 
lacZ expression cassette driven by the HCMV IE promoter was inserted into the Nsil site in 
UL43 (np 94911) (Fig. 2) by Dr. Alistair McGregor.
Three other wild type HSV-1 strains were used, F (Ejercito et al., 1968), SC16 a low 
passage isolate (Hill et a l, 1975); and HSV-1 strain HFEM a high passage syncytial strain 
(Halliburton et al., 1980).
R6012 is a gC negative form of HSV-1 strain F (Fig. 3). (Sears et al, 1991)
SC16-AUL44-Z and HFEM-AUL44-Z were constructed as described by Griffiths et al.,
1998 (Fig. 4) with the UL44 gene disrupted by insertion of a lacZ expression cassette 
(Forrester et al., 1992).
4 .3
Particle to p.f.u ratio.
Herold et al., (1991) showed that KOS gC negative virions demonstrated delayed adsorption 
kinetics and had a lower specific infectivity as measured by a higher particle to p.f.u ratio.
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The viruses used in this study, both wild type and mutant, had their particle to p.f.u ratio 
measured. In all cases the wild type parent and its gC negative mutant had similar particle to 
p.f.u ratios (Table 4.1), differing by two fold at most. This is in contrast to the defect in the 
specific infectivity of the gC negative virus used by Herold e ta l  (1991).
Since the particle to p.f.u ratios of the viruses used were all within normal limits, some doubt 
was cast on the idea that gC has an important role in the infection process through binding 
cell surface proteoglycans.
4 .4
Binding of radioactively labelled virions to BHK21/C13 and C6 gliomal 
cells.
Radiolabelled virions of HSV-1 strain 17 and its gC negative mutant were purified (see 
methods section 3.5) and binding to BHK21/C13 and C6 glioma cells carried out. This 
method extends the particle to p.f.u ratio measurements looking only at deficits in binding 
and does not rely on virus infectivity. It allows us to look at absolute levels of adsorption 
(See section 3.11 for method). The main problem in this assay is the high background level 
of radioactivity. Herold et al. (1991) recorded that significantly fewer KOS gC negative 
virions bound to Hep-2 cells than wild type or gB negative virions. However the results 
obtained in this case did not agree with that finding.
There was no difference between the ability of HSV-1 strain 17 wild type to bind to 
BHK21/C13 and C6 cells (Fig. 5). Similarly the gC negative virus bound equally well to 
both cell lines in the binding of the gC negative virus (Fig. 6). Both HSV-1 strain 17 wild 
type and its gC negative mutant bind equally well on both cell lines (Fig. 7 and 8), in the case 
of these figures the values shown are values obtained when the level of background binding 
(binding at t=0) is removed. This allows for differences in background radioactivity of 
different virus preparations.
4 .5
Adsorption kinetics of HSV-1 strain 17 wild type virus and its gC negative 
mutant to BHK21/C13 cells.
Assays were carried out as described in section 3.7, in order to examine the kinetics of viral 
adsorption to the cell surface. Graphs in the following sections show how adsorption varies 
over time. Initially adsorption is rapid and as time progresses the rate of adsorption slows as 
it approaches a maximum. Values are expressed as a percentage of the final adsorption at
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t240. Thus all graphs have a final adsorption of 100% and no account is made of the 
absolute level of adsorption.
In order to further examine whether the HSV-1 strain 17 gC negative mutant was impaired in 
adsorption we looked at the adsorption kinetics of this virus as compared to the wild type on 
BHK21/C13 cells. Initial experiments indicated that the HSV-1 strain 17 gC negative mutant 
was not impaired for adsorption to BHK21/C13 cells. This result differed from published 
data (Herold 1991, Trybala 1994) which showed a lag in viral adsorption of gC negative 
virions. In order to confirm our observations, the experiments were repeated and subsequent 
experiments confirmed that there was no difference between the gC negative virus and its 
wild type parent.
Figure 9 shows the results of these experiments. Values shown represent the average of 
three experiments with the standard deviation indicated. The viruses show t50 values (the 
time taken to reach 50% adsorption levels) of 61 and 42 minutes for the wild type and mutant 
respectively (see table 2).
Adsorption experiments were also carried out using strain 17 wild type and the strain 17 gC 
negative viruses containing a lacZ expression cassette in the UL43 locus (Fig. 10). UL43 is 
a non-essential gene with no role in adsorption (MacLean et al, 1991; C. MacLean - personal 
communication). The results indicate no difference in the adsorption pattern observed for the 
lacZ gC negative mutant and the lacZ wild type (Fig. 10, Table 2). In a comparison of all 
four strain 17 viruses no significant difference was observed (Fig. 11, Table 2).
4 .6
Rate of penetration of HSV-1 strain 17 wild type and its gC negative mutant 
into BHK21/C13 cells.
Following the observation that there was no difference between the viruses in adsorption as 
judged by specific infectivity, radioactively labelled virion binding and kinetics, the rate of 
penetration of the viruses was examined. This was assessed by determining the rate at which 
adsorbed virus became resistant to inactivation by a low-pH citrate buffer (section. 3.8). 
Herold et a l (1991) concluded that there was a lag in penetration of KOS gC negative 
virions. In contrast, the results presented here in Figure 12 show that HSV-1 strain 17 and 
its gC negative mutant displayed no difference in the rate of penetration into BHK21/C13 
cells. They displayed similar t50 values (time taken for 50% of the total virions to penetrate 
the cell) at 14.1 and 12.8 minutes respectively.
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4 .7
Intracranial pathogenicity.
Experiments to determine the pathogenicity of the strain 17 gC negative mutant as compared 
to its parent, HSV-1 strain 17 were carried out in three week old female Balb/C mice 
following intracranial inoculation (section 3.13). Tenfold serial dilutions of strain 17 wild 
type and the gC negative mutant were inoculated into the left cerebral hemisphere of the mice. 
Deaths from encephalitis were scored up to 21 days post inoculation and the results are 
shown in Table 4.3. The viruses displayed no significant difference in pathogenicity with 
LD50 values of clO1 and 5xl0! respectively.
4 .8
Peripheral pathogenicity and latency studies of HSV-1 strain 17 and its gC 
negative mutant.
The ability of the HSV-1 gC negative mutant to reactivate from latency was examined using 
the mouse footpad model (see section 3.12). Groups of four week old female Balb/C mice 
were inoculated in the right rear footpad with varying doses of wild type strain 17 and gC 
negative strain 17 and monitored daily for signs of illness or death. Six weeks post 
inoculation, surviving mice were sacrificed and the ten ipsilateral ganglia supplying the 
footpad removed and assayed for reactivation as described in section 3.12. The LD50 data 
following footpad inoculation are summarised in Table 4.4.
HSV-1 strain 17 has a LD50 of 105 p.f.u/mouse compared to the gC negative mutant at 106. 
This ten fold difference is not significant. The reactvation frequency is shown in Figure 13, 
and shows that the two viruses behave similarly.
4 .9
Analysis of the structures of the virus DNAs used in this study.
To confirm the genotype of the viruses, DNA was prepared from all of the viruses used in 
this study and analysed by Southern blotting. The DNA was digested with BamHl (section 
3.16), Southern blotted (section. 3.18) and probed with radiolabelled Kpnld (np 90383- 
103012).
Figure 14 is a diagrammatic representation of the structure and np of the relevant sites for 
each virus. Figure 15 is the autoradiogram produced, showing the expected profiles for each 
virus.
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All viruses contain bands of 8055, 3866 and 717kbp with the 3866 and 8055kb bands being 
fainter since the probe only spans part of their length.
The lanes containing wild type strain 17 (lane9), SC16 (lane 4), HFEM (lane 3), F (lane 11) 
and the mutant strain 17 gC negative viruses (lanes 6 and 7) show a band of 6640kb, the 
fragment spanning UL44 and UL43.
As expected in lane 10 containing R6012 the 6640 band is reduced due to the 1372bp 
deletion in UL44, producing a band of 5267bp.
The lanes containing SC16-AUL44-Z (lane 4) and HFEM-AUL44-Z (lane 2) have bands of
5.1 kb and 600bp.
The lacZ expressing strain 17 viruses (lanes 6 and 7) have bands of 3.3kb and 7.3kb.
4.10
Analysis of gC expression of the wild type HSV-1 strains and their gC 
negative mutants.
All of the viruses used in this project were analysed by Western blotting (section 3.19) in 
order to determine if they did or did not produce gC. All produced the expected pattern with 
HSV-1 strain 17 wild type, strain 17 wild type lacZ expressing virus, SC 16, HFEM and F all 
expressing gC; while the HSV-1 strain 17 gC negative mutant, the lacZ expressing form of
the mutant, SC16-AUL44-Z, HFEM-AUL44-Z and R6012 did not produce glycoprotein C
(Fig. 16).
The marker lane shows the 66 and 46kD markers. There is a 46kD cellular band which is 
detected non-specifically by the antibody. A gC band is observed in all the wild type lanes. 
Another band is visible below gC in the wild type virus lanes, this is a precursor form of gC 
(pgC). Due to differences in the rate of progression of infection, HSV-1 F shows more pgC 
than gC, and two precursor bands are visible. The lanes containing gC negative mutants do 
not display any bands corresponding to gC or pgC.
4.11
Adsorption characteristics of other HSV-1 strains and their gC negative 
counterparts on BHK21/C13 cells.
As stated in section 4.5, these experiments were initially carried out using HSV-1 strain 17 
alone. It was shown that there was no difference between HSV-1 strain 17 wild type and gC 
negative virus (Fig. 9), or between lacZ expressing variants of these viruses (Fig. 10).
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Due to the difference between the published and our observed data we obtained more gC 
negative viruses in order to see if this was a strain dependent event. Work which was later 
published (see discussion) agreed that there was no difference in the rate of adsorption of two 
of the gC negative viruses used here (SC 16 and HFEM) as compared to the wild type parents 
(Griffiths et al, 1998).
No difference was observed between HSV-1 strains SC16 and SC16-AUL44-Z (Fig. 17),
HFEM and HFEM-AUL44-Z (Fig. 18) or HSV-1 strain F and R6012 (Fig. 19).
A comparison was also made between each vims and the HSV-1 strain 17 wild type. Again 
no difference in adsorption characteristics was observed. HSV-1 strain 17 wild type shows
the same pattern of adsorption as SC 16 (Fig. 20), SC16-AUL44-Z (Fig. 21), HFEM (Fig.
22), HFEM-AUL44-Z (fig. 23), F (Fig. 24) and R6012 (Fig. 25).
The t50 values were very similar and are shown in Table 2.
4.12
Adsorption characteristics of all HSV-1 viruses and their gC negative 
counterparts on Vero cells.
Following the results obtained on BHK21/C13 cells it was decided to look at the different 
viruses (HSV-1 strain 17, SC 16, HFEM, F and their gC negative mutants) in various cell 
lines. Vero cells were chosen since they are permissive for HSV and produce visible plaques. 
The observations made were similar to those made on BHK21/C13 cells. HSV-1 strain 17 
wild type and gC negative viruses showed the same pattern of adsorption (Fig. 26), as did
their lacZ expressing variants (Fig. 27). SC16/SC16-AUL44-Z (Fig. 28), HFEM/HFEM-
AUL44-Z (Fig. 29) and F/R6012 (Fig. 30) were also indistinguishable in their adsorption 
characteristics.
As before SC16 and its gC negative form SC16-AUL44-Z, HFEM and HFEM-AUL44-Z, F 
and R6012 were compared to the HSV-1 strain 17 wild type. No differences were observed 
as can bee seen in the following figures SC16 (Fig. 31), SC16-AUL44-Z (Fig. 32), HFEM
(Fig 33), HFEM-AUL44-Z (Fig. 34), F (Fig. 35) and R6012 (Fig. 36).
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4.13
Comparison of adsorption characteristics as detected by Giemsa/p- 
galactosidase staining.
We wanted to determine the adsorption levels of the viruses (both wild type and gC negative) 
in cells that did not produce countable plaques by Giemsa staining (HeLa, section 4.14 and 
3T6, section 4.15). We therefore decided to measure plaquing ability by lacZ expression and
p-galactosidase staining.
Prior to doing this we needed to ensure that using the two forms of staining (p-
galactosidase/Giemsa) gave similar results. An adsorption experiment was performed in 
duplicate with HSV-1 strain 17 wild type, lacZ expressing strain 17, the strain 17 gC 
negative mutant and gC negative lacZ; one set being stained with Giemsa (the non-lacZ 
viruses, 17+ and gC-) and the other with X-gal (the lacZ expressing viruses, 17+lacZ and 
gC- lacZ). Identical results were obtained in terms of number of plaques using the two 
methods of staining (Fig. 37). As reported in section 4.5 both viruses showed similar 
adsorption rates.
4.14
Adsorption profile of HSV-1 strain 17 wild type and the lacZ expressing gC 
negative mutants on HeLa cells.
We proceeded to look at the adsorption rates of all lacZ expressing viruses on HeLa cells. 
Comparisons were made between strain 17 wild type lacZ and gC negative lacZ (Fig. 38).
Comparisons were also made between strain 17 lacZ and SC16-AUL44-Z (Fig. 39), and
HFEM-AUL44-Z (Fig. 40). We had previously shown in BHK21/C13 cells (section 4.5
and 4.11) that strain 17 wild type displayed the same level of adsorption as the wild type 
SC 16 and HFEM viruses, and therefore we felt that it could be used in place of these viruses 
on non-plaquing cell lines to provide a guide as to the behaviours of parental viruses.
No analysis of HSV-1 strain F or R6012 were possible as lacZ expressing versions of these 
viruses were not available.
In all cases the adsorption kinetics of the different viruses were similar to HSV-1 strain 17 
lacZ.
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4.15
Adsorption profile of HSV-1 strain 17 wild type and the lacZ expressing gC 
negative mutants on 3T6 cells.
As in section 4.14 it was not possible to examine the adsorption of HSV-1 strain F or its gC 
negative mutant R6012 on this cell line because of the lack of availability of lacZ expressing 
versions.
Following the same comparisons as in section 4.14 we found that the HSV-1 strain 17 lacZ 
expressing viruses (17+ and gC negative) produced a similar adsorption pattern (Fig. 41).
Figure 42 shows the comparison between SC16-AUL44-Z and strain 17 lacZ, while figure 
43 shows that there was also no difference between strain 17 lacZ and HFEM-AUL44-Z.
4.16
Heparin inhibition assays.
HSV displays reduced binding to cell surfaces that have been enzymatically stripped of 
heparan sulphate or to mutant cells that do not produce heparan sulphate (see discussion - 
section 5). Reductions in levels of cell surface heparan sulphate produce a reduction in viral 
infectivity that is accompanied by a reduction in viral adsorption. HSV virions can bind to 
immobilised heparin and soluble heparin can block the binding of virions to cells (WuDunn 
and Spear, 1989). This is assumed to be due to blocking heparan sulphate-binding sites on 
the virion surface. It has also been shown that heparin binding proteins such as platelet factor 
4 and fibroblast growth factor (FGF) can inhibit HSV adsorption and plaque formation, 
probably through competition for receptor sites associated with the cell surface heparan 
sulphate. The addition of exogenous heparin can block the adsorption process but addition of 
the other glycosaminoglycans can not do this.
Exogenous heparin was used in order to inhibit the binding of virus to cells. Glycoprotein C 
negative mutants should be less affected by the interference than wild type viruses (Herold,
1995). A possible explanation for this is that since gC negative virions are deficient in a 
receptor binding route; the attachment to heparan sulphate proteoglycans is no longer 
available for blocking by exogenous heparin.
A comparison was made of the ability of heparin to block the adsorption of the HSV-1 strains 
17, F, SC 16 HFEM and their gC negative derivatives. All of the parental viruses were 
shown to be sensitive to varying concentrations of heparin, although the dose response is not 
identical and on the whole the gC negative mutants are less sensitive to heparin than their 
parental viruses.
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Initially the experiment was carried out using HSV-1 strain 17 viruses only (Fig. 44). All 
viruses were inhibited in binding by heparin (Fig. 45).
Later experiments using all viruses showed that they all followed the same pattern of blocking 
by heparin (Fig. 46).
As expected, SC16-AUL44-Z was less affected by the addition of heparin than SC 16 (Fig.
47). HFEM-AUL44-Z appeared to be less affected by the application of exogenous heparin
than HFEM (Fig. 48), however it is not certain if this difference is significant.. This was 
also the case with HSV-1 strain F, were R6012 appeared to be less affected by exogenous 
heparin than the wild type F (Fig. 49).
All of the gC negative viruses were compared to each other (Fig. 50, see scetion 3.9 for
method), and they showed differing levels of inhibition in adsorption, SC16-AUL44-Z was
the least affected and the HSV-1 strain 17 gC negative lac Z expressing virus appeared to be 
most inhibited in binding.
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5. Discussion.
As discussed in chapter one the entry of herpes simplex virus (HSV) into host cells involves 
a cascade of interactions between several virion envelope components and molecules on the 
cell surface. The entry of the virus can be broken down into two parts: adsorption (section 
1.4.1) where the virus attaches to the cell surface membrane; and penetration (section 1.4.2) 
where the nucleocapsid enters the cytoplasm. Attachment of the virus is the first step in the 
entry process and is one of the major determinants of cell and tissue tropism. Glycoproteins 
B and C have been shown to be involved in the initial attachment phase when positively 
charged residues interact with negatively charged heparan sulphate moieties. This initial 
attachment facilitates a second, stronger attachment where gD binds a cellular receptor (see 
section 1.2.3) to form a fusion bridge. Following attachment the virus penetrates the cell by 
fusion of the virus envelope with the cell plasma membrane. Virus penetration is a highly 
complex process involving the cooperative activities of multiple viral glycoproteins (gD, 
gH/gL and gB).
There are several lines of evidence identifying heparan sulphate as the initial receptor for HSV 
infection. Firstly, heparan sulphate proteoglycans are found on the surface of most vertebrate 
cell types, including those that are susceptible to HSV infection (Gerber et al., 1995a and b, 
Herold et al, 1991; Lycke et a l, 1991; Subramanian et a l, 1994; WuDunn and Spear, 
1989). Secondly, enzymatic removal of heparan sulphate from the cell surface or the use of 
cell lines selected to be lacking in heparan sulphate makes the cells at least partially resistant to 
HSV infection through a reduction in viral attachment (Banfield et a l, 1995; Grunheid et a l, 
1993; Shieh et a l, 1992). Finally, heparin inhibits viral infection by blocking the heparan 
sulphate binding domain on the virus envelope (Herold et al, 1995, 1996, Shieh and Spear, 
1994). Both gC and gB bind heparin-sepharose individually and can be eluted with soluble 
heparin (Herold et a l, 1991). In general during infection with herpesviruses, more that one 
envelope protein plays a critical function in virus adsorption to cellular receptors. Kuhn et al 
(1990) showed that the interactions of gC and gB with the cell surface occur independently 
and do not involve complex formation. Thus both gC and gB must be considered to be the 
principal mediators of HSV-1 attachment. Campadelli-Fiume et a l (1990) presented 
evidence that there are at least two pathways for viral attachment to cells; one mediated by gC 
with the other independent of gC and possibly these pathways make different contributions in 
different strains of virus or in different cells.
Trybala et al, (1993) could not exclude the use of a heparan sulphate-binding factor as a 
substitute for gC in gC deficient virions. Glycoprotein C may also interact with a specific 
receptor other than heparan sulphate, possibly complement receptor 1 (CR1) (Sears et a l,
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1991). It has been shown that certain modified heparin components differentiate the binding 
of HSV-1 gC and gB with cell surface heparan sulphate (Herold et al., 1995) and this 
difference may therefore play a role in cell tropism and binding ability.
Herold et al (1996) provided evidence supporting the idea that the envelope glycoproteins of 
HSV-1 and HSV-2 interact with different affinities for different structural features of heparin. 
This may also be true between HSV-1 strains explaining the different observations regarding 
the role of gC in viral binding (see this thesis and Griffiths et al, 1998).
During the course of this project it was found that gC negative viruses displayed no 
discernible phenotype on a range of cells (Griffiths et al., 1998); a result that contrasts with 
other reports. These previous studies assume that gC plays a principal role in the adsorption 
of virus to cells. This assumption arises from the finding that significantly fewer gC negative 
virions than wild type virions bind to cells under conditions approaching saturation of 
available sites on the cell surface. (Herold et al., 1991).
It was previously reported that virions which lack gC bind to cells with reduced efficiency 
(Fuller and Spear, 1985; Langeland et al, 1990; Herold et al., 1991; Trybala et al., 1994).
In the results section of the thesis presented here, a study is described which was aimed at 
examining the adsorption kinetics of several HSV-1 strains (17+, F, SC 16, and HFEM) 
lacking gC on a range of cell types (BHK, 3T6, HeLa and Vero). Prior to this work, and 
that by Griffiths (Griffiths et al., 1998), studies of the role of gC in non-polarised cells were 
limited to the KOS strain (Langeland et al., 1990; Herold et al, 1991, 1994; Trybala et al., 
1994).
The study presented here suggests that deletion of gC does not significantly affect the binding 
of wild type HSV-1 of the strains used to the cell lines examined. However, gC is a heparin- 
binding glycoprotein and therefore has a role in viral binding, possibly this role is more 
significant on other cell lines or in different strains or under specific conditions.
Glycoprotein C negative virions were indistinguishable from their wild type parents in their 
adsorption characteristics, and all viruses used had particle to p.f.u ratios that were within the 
normal range. An investigation into the inhibition of virus adsorption by exogenous heparin 
is also described. Some strains adsorbed more efficiently in the presence of exogenous 
heparin. The heparin inhibition data are not simple to interpret since heparin binds weakly to 
gB as well as binding to gC and thus gB may have a role in triggering the fusion reaction 
(Shieh and Spear, 1994). It is however difficult to countenance the idea that gC has an 
important role in adsorption with the observation that gC negative mutants are of higher 
specific infectivity than wild type viruses in the presence of heparin.
One possible consideration is that all the wild type viruses used in the study lacked a 
functional gC and as result were defective before mutagenesis of the glycoprotein. This
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suggestion is however most unlikely since a range of viral strains from different sources were 
used. All wild type viruses were gC positive by Western blotting while all mutant viruses did 
not express gC as judged by this method; additionally the profile produced by Southern 
blotting detected no obvious deletion.
These observations suggest that under the conditions tested (virus strains and cell types) the 
role of gC in the adsorption process can be substituted for by gB and that the binding of 
heparin to gC causes a decrease in the infectivity of the virion. Cell surface 
glcosaminoglycans are required for HSV-1 infection and wild type viruses mediate their 
binding to them via gB and gC. A possible explanation of the higher specific infectivity of 
virus in the presence of heparin is that the binding of exogenous heparin to gC sterically 
inhibits adsorption through gB.
A deletion mutant lacking both gC and gB coding sequences was demonstrated to be 
substantially impaired in binding (Herold et al., 1994), suggesting a role for gB in heparan 
sulphate binding and adsorption. This mutant did however retain some residual attachment 
ability, indicating either that other viral glycoproteins have limited heparan sulphate binding 
activity or that additional receptors are recognised in the absence of heparan sulphate binding. 
The paper published by Laquerre et al., (1998) reports a decreased capacity for attachment of 
a gB mutant deleted in the heparan sulphate binding domain. This report contrasts with 
previous studies showing gB negative mutants to have the same level of binding as wild type 
virus (Cai et al, 1988).
Laquerre et al., 1998 follow on from these observations and examine the role of gB in 
adsorption. They state that gB contributes less to viral binding of heparan sulphate than gC 
does. In their report, even when the heparan sulphate binding region of gB and all of gC are 
deleted there remains a twenty percent residual binding activity. This residual binding was 
also seen using wild type KOS on sog9 cells; a cell line lacking glycosaminoglycans, 
indicating that it is heperan sulphate independent.
They also show that the heparan sulphate recognition sequence of gB differs from earlier 
sequences of the heparan sulphate binding element of gC (Feyzi et al., 1997, Trybala et al,
1996). The heparan sulphate recognition sequence of gC of PRV is different from that of 
HSV-1 (Herold et al., 1996, Trybala et al., 1996). Thus the specific heparan sulphate 
proteoglycans recognised by different viruses may vary; it is also possible that they may vary 
between strains.
Tal Singer et al. (1995) showed that much of gC binding to cells occurs via heparan sulphate. 
They developed an ELISA to examine the binding of purified gC to L, Vero and BHK cells, 
and found that gC bound to cells in a dose dependent manner eventually reaching saturation. 
Further experiments involving the enzymatic treatment of cells and the use of heparan
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sulphate deficient cell lines demonstrated that gC binds to cell surface HS. However, they 
found no difference in the binding ability of a biotinylated baculovirus expressing gC to two 
mutant cell lines gro2C and sog9, even though sog9 cells are ten times more resistant to HSV 
infection that gro2 cells. They regard this as suggesting that virion components other than 
gC, possibly gB, are responsible for the difference in infectivity and that the residual binding 
of gC to the mutant cell lines may involve molecules other than glycosaminoglycans.
This group also noted that soluble gC did not inhibit plaque formation even though it is 
considered important for attachment. This plaque inhibition assay argues against a significant 
role for gC in the entry process. Another observation made by this group was that the 
interaction of soluble gC with cells blocks the attachment of HSV-1. Soluble gC2 also 
blocked HSV-1 attachment indicating that gCl and gC2 bind to the same or similar receptors. 
The group argues that the blocking of attachment does indicate a significant role for the
glycoprotein in attachment as it may be a weak interaction that occurs at 4°C during their
assay that can be overcome by gB or other viral factors at the higher temperatures used in the 
plaque assays.
They made a mutant form of gC lacking residues 33 to 123 which when expressed in a 
baculovirus system bound significantly less well to cells than wild type gC expressed in the 
same system (Tal-Singer et al, 1995), and competed poorly with the wild type for binding. 
These results suggest that residues 33-123 are important for gC attachment to cells. 
However, both the mutant and wild type forms of gC bound to immobilised heparin, 
indicating that the binding of these proteins to the cell surface involves more than a simple 
interaction with heparan sulphate. It is also possible that other viral components e.g. gB are 
capable of attachment via the non-heparan sulphate binding suggested here.
Despite the weight of historical data implicating gC of the alphahepesviruses in the adsorption 
of virions to the cell surface, monoclonal antibodies and polyclonal anti-gC antibodies show 
low or moderate inhibition of attachment (Fuller and Spear 1985) and the results of this study 
and the data published by Griffiths et a l (1998) suggest that gC of the HSV-1 strains used 
plays no significant role in this process. These data are similar to those obtained for the only 
HSV-2 strain examined so far (Gerber et al., 1995) which reports no significant difference 
between wild type parental strain (G) and a gC deletion mutant in the number of virions 
binding to Hep-2 cells. They also report normal particle to p.f.u ratios for their gC-2 
negative mutant.
Nor was there a delay in the penetration of adsorbed HSV-2 (G) on either Hep-2 or Vero 
cells. The genes for gC-1 and gC-2 have diverged to a greater extent than most of the other 
glycoprotein genes. Glycoprotein C-2 is significantly smaller than gC-1 (Dowbenko and 
Lasky, 1984; Swain et al, 1985; Fink et al., 1983) and diverges from its HSV-1 counterpart
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at the amino terminus and also differs in the extent of glycosylation (Dall'Olio et al., 1985; 
Serafini-Cessi et a l, 1984). This may indicate the lack of importance of this gene for viral 
binding. Alternatively this divergence in gC may indicate that differences in the interactions 
of HSV-1 and 2 with cell surface heparan sulphate occur, possibly influencing viral tropism. 
However, gC-1 and 2 use the same receptor (Tal-Singer et al, 1995) and demonstrate similar 
dissociation constants.
At the time they were published, the Gerber results were taken to suggest that gC-2 differed 
widely from gC-1 since it did not play the predominant role in HSV-2 binding. However, in 
the light of the results presented here and the work of Griffiths et al, 1998, it is suggested 
that gC-1 and 2 play similar roles, with gC of HSV-1 strain KOS possibly being slightly 
different. It is possible that the differences observed are due to differences in the role of gB 
and not gC with the relative contributions of the individual glycoproteins to binding being 
different across strains.
Neomycin and polylysine inhibit the binding of HSV-1 to cells. HSV-1 KOS was less 
sensitive to neomycin than strain 17syn+ indicating a strain dependent sensitivity. There is 
however some disagreement about how this inhibition occurs. Campadelli-Fiume et al 
(1990b) found that wild type HSV-1 and gC negative mutants of HSV-1 and HSV-2 are 
blocked by neomycin and polylysine from attaching to BHK cells. They concluded from 
these results that the target of the polycations is the interaction of a virion component other 
than gC with its receptor in BHK cells.
Glycoprotein C is present in the region of HSV-1 sensitive to both neomycin and poly lysine 
(Langeland et al, 1990) although a gC negative mutant had similar drug sensitivity to that of 
the parental wild-type strain. These results suggest that gC is not the protein associated with 
the sensitivity to polylysine and neomycin, indicating that gC may not be significantly 
involved in binding. However, Herold and Spear (1994) report that neomycin partially 
inhibited the gC dependent binding of virions and that plaque formation by both gC positive 
and gC negative strains of HSV-1 was inhibited by neomycin. Thus they conclude that 
neomycin inhibits HSV-1 infection by competing with gC-1 for binding heparan sulphate 
glycosaminoglycans.
Since the information provided by the work shown here suggests that gC does not have a 
significant role in viral adsorption and gC has long been known to be dispensable in vitro, it 
is possible that the main role of gC takes place in vivo.
Genes that are dispensable for growth in cell culture may extend the host range of the virus in 
vivo. Many mutants that do not express gC grow as well as wild type HSV-1 in culture and 
thus gC is considered to be nonessential for virus replication in vitro. However, nearly all 
clinical isolates of HSV-1 express gC suggesting that gC may have an important role in virus
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replication or survival in humans (Holland et al., 1984). In the study presented here the gC 
negative mutant displayed the same rate of reactivation as the wild type virus indicating that 
the role of gC does not lie in latency/ reactivation of the virus in the mouse footpad model.
As already mentioned in section 1.4.5, gC is capable of binding complement component 
C3b. HSV-1 and 2, PRV, BHV-1 and EHV-1 all bind C3b, and this function has been 
mapped to gC or its homologues (Eisenberg et al., 1987, Friedman et a l, 1984, Huemer et 
al., 1993). Glycoprotein C also protects HSV-1 infected cells from lysis by antibody plus 
complement; as well as against lysis mediated by complement alone (Hidaka et al, 1991). 
Glycoprotein C negative mutant strains are unable to bind C3b and are approximately 5,000 
fold more susceptible to complement neutralisation than wild type virus which indicates that 
gC has a vital role in protection against complement neutralisation (Friedman et al, 1996). 
Lubinski et al., 1998 demonstrated that gC is a virulence factor wihose deletion has a 10-100 
fold effect on virulence.
Differences between strains are noted in complement protection as well as for the role of gC 
in adsorption (Friedman etal., 1996, see section 1.4.3).
Friedman et a l (1996) also suggest a link between the complement modulation of gC and its 
binding to heparan sulphate. They point to the observation that heparin is an inhibitor of 
complement activation and thus gC binding to heparan sulphate may add to the inhibitory 
activity mediated by gC. Another observation that suggests a link is that of Sears (1994), 
showing that mammalian C3 receptors are widely distributed on cells and that activated C3 
fragments on HSV may enhance infection by promoting virus attachment to complement 
receptors on cells.
It is possible that in vivo HSV gC functions are supplemented or enhanced by the function of 
other viral glycoproteins as appears to be the case in PRV (Mettenleiter et al, 1988).
Another possible role for gC in vivo is to provide a docking mechanism for the virus that 
mediates rapid adhesion to cells allowing the interaction of gD with its receptors. Haywood 
1994, suggests that low-affinity binding to an abundant receptor lets the virus roam over the 
cell surface by making and breaking weak bonds until it reaches a second receptor. This 
docking mechanism may be one of the roles played by HSV gC and could possibly contribute 
to the in vivo survival of the vims.
There is a large amount of evidence implicating gC in the adsorption of alphaherpesviruses. 
However, these results and those of Griffiths et a l, (1998) and Gerber (1995) suggest that 
the role of gC in adsorption may be strain dependent.
It is also possible that different HSV proteins may be involved in adsorption; the virion 
protein responsible may not be a glycoprotein since adsorption can occur in the absence of 
normal glycosylation (Langeland et al, 1990).
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The results presented here lead to the assumption that the heparan sulphate binding function 
of gB is sufficient to mediate vims attachment to heparan sulphate and to compensate for the 
absence of gC.
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Appendix
Figures relating to Chapter 4: Results
Figure 4.1: Structure of the HSV-1 strain 17 gC negative mutant.
A. An expansion of the HSV-1 genome showing the UL44 gene encoding gC. The 
positions of the 5' and 3' ends of UL44 are marked. The position of the Xbal site where 
the insertion is made is also shown. All n.p. are according to McGeoch et al., 1988a.
B. An expansion of the Xbal site, showing where Xbal cuts.
C. An expansion of the Xbal site containing the 4bp insert (the insert is marked in the 
diagram) producing a stop codon towards the end of the ORJF close to the transmembrane 
domain (indicated by solid box). The mutant produces a truncated form of the 
glycoprotein that is secreted and is not incorporated into the virion.
Xbal
96311 96751 97844
UL44
\
T C T A G A
A G A T C T
4bp insert
T C T A G C T A G A
A G A T C G A T C T
Figure 4.2: Construction of lacZ expressing HSV-1 strain 17 viruses.
p35
NSil (94911)
I
Oligo insertion at Nsil site generates 
p35(PacI)
HSi I insertion oliqo
NSF 5 ' TTTAATTAAACTAGTCTCGAGAGATCTTTAATTAAATGCA 3 *
NSB 3 ’ ACGTAAATTAATTTGATCAGAGCTCTCTAGAAATTAATTT 5 '
I I I I I I .
NSil Pacl Spel Xhol Bglll PacI NSil
i CMVlacZ cassette cloned into Xhol site on p35(PacI)
BamHI
CMV lac Z
NSil Pacl Spel
Xhol Xhol
Bglll Pacl NSil
HSV (91610-94911) HSV (949112-96751)
p35CMVZ(Pacl)
Recombine with HSV-1 at UL43 locus 
to generate blue virus. Once isolated 
viral DNA digested with Pacl can be used 
to produce HSV-1 with unique cloning site 
for direct insertion of lacZ neuronal 
I rpromter cassettes. ✓
Figure 4.3 Structure of R6012.
The top line of the diagram shows the HSV-1 strain F genome and below this is an 
expansion of the Hpal-BamHl fragment (93730-98250). The UL44 gene was disrupted 
by digestion at the Nhel (96276) and EcoRV (97649) sites, resulting in a 1,371 bp 
deletion after ligation of the ends (Sears et al., 1991).
UL44
96311 97844
NheI EcoRV
1,371 bp I-------
96276 97649
BamHI
98250
Figure 4.4: S tructure of SC16-AUL44-Z / HFEM -AUL44-Z.
The top line of the diagram shows the HSV-1 genome and below this is an expansion of 
the Kpnlt fragment. The UL44 gene was disrupted by digestion at the NheI (96276) and 
EcoKW (98649) sites before insertion of a lacZ expression cassette (Forrester et al, 
1992).
Kpnla b b’ a’ c’
UL45UL43UL42 UL46UL44UL41
UL44 9784496311
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Figure 4.5: Binding of radioactively labelled strain  17 wild type to C6 
gliomal cells and BHK21/C13 cells.
This graph shows that the virus has a similar pattern of binding to both cells lines as 
judged by measuring bound counts.
Binding of labelled 17+.
Figure 4.6: Binding of radioactively labelled strain 17 gC negative mutant 
to C6 gliomal cells and BHK21/C13 cells.
This graph shows that the virus has a similar pattern of binding to both cells lines as 
judged by measuring bound counts.
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Figure 4.7: Binding of radioactively labelled strain 17 wild type and its gC 
negative mutant to C6 gliomal cells.
This graph shows that both viruses have similar levels of binding to C6 glioma cells 
judged by measuring bound counts.
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Figure 4.8: Binding of radioactively labelled strain 17 wild type and its gC 
negative mutant to BHK21/C13 cells.
This graph shows that both viruses have similar levels of binding to BHK21/C13 
glioma cells as judged by measuring bound counts.
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Adsorption experiments.
The graphs presented here in figures 4.9 - 4.11 and 4.17 to 4.43 show the level of 
adsorption at each timepoint. In each experiment the adsorption at the final timepoint for 
each virus (t240) is considered to be 100%. Where error bars are present they represent 
the standard deviation between experiments. Values given for each timepoint are the 
average of triplicate repeats within an experiment. The t50s for each graph are tabulated 
in Table 4.2.
Cmparisons between viruses were always made within the same assay.
Figure 4.9: Adsorption kinetics of HSV-1 strain 17 and its gC negative 
mutant on BHK21/C13 cells.
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Figure 4.10: Adsorption kinetics of HSV-1 strain 17 lacZ and its gC 
negative lacZ expressing mutant on BHK21/C13 cells.
No standard deviation is shown due to the fact that there were insufficient repeats of the 
assay for statistical analysis.
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Table 4.2: Adsorption t50 values.
This table shows the t50 value (the time in minutes taken to reach 50% adsorption) for 
each pair of viruses being compared and the cell line used.
The table shows the values for all cell lines used in this project (BHK21/C13, Vero, HeLa 
and 3T6).
Values were obtained from a series of different experiments.
Cell line Viruses t50
BHK21/C13 17+ 42
gC- 61
BHK21/C13 17+lacZ 60
gC- lacZ 62
BHK21/C13 gC- 43
gC- lacZ 36
BHK21/C13 SC16 63
SC16gC- 48
BHK21/C13 HFEM 58
HFEMgC- 47
BHK21/C13 F 44
R6012 48
BHK21/C13 17+ 42
17+ lacZ 48
BHK21/C13 17+ 42
gC-lacZ 36
BHK21/C13 17+ 38
SC16 63
BHK21/C13 17+ 40
SC16gC- 44
BHK21/C13 17+ 37
HFEM 42
BHK21/C13 17+ 36
HFEMgC- 58
BHK21/C13 17+ 56
F 47
BHK21/C13 17+ 56
R6012 62
Cell line Viruses t50
Vero 17+ 52
gc- 57
Vero 17+ lacZ 53
gC- lacZ 61
Vero gc- 53
gC- lacZ 61
Vero SC16 56
SC16gC- 73
Vero HFEM 33
HFEMgC- 29
Vero F 52
R6012 53
Vero 17+ 53
17+ lacZ 59
Vero 17+ 53
gC-lacZ 61
Vero 17+ 62
SC16 56
Vero 17+ 52
SC16gC- 69
Vero 17+ 33
HFEM 33
Vero 17+ 33
HFEMgC- 29
Vero 17+ 53
F 52
Vero 17+ 53
R6012 53
Cell line V iruses t50
HeLa 17+ lacZ 69
gC-lacZ 73
HeLa 17+ lacZ 70
SC16gC- 66
HeLa 17+ lacZ 76
HFEMgC- 77
3T6 17+ lacZ 58
gC-lacZ 55
3T6 17+ lacZ 58
SC16gC- 48
3T6 17+ lacZ 56
HFEMgC- 59
Figure 4.11: Adsorption kinetics of all HSV-1 strain 17 viruses used in 
this study on BHK21/C13 cells.
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Figure 4.12: Rate of penetration into BHK21/C13 cells by HSV-1 strain 17 and 
its gC negative m utant.
This figure shows the rate of viral penetration as compared to time. Both HSV-1 
strain 17 and its gC negative mutant display the same rate of penetration.
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Table 4.3: Pathogenicity studies of HSV-1 strain 17 wild type and gC 
negative mutant following peripheral inoculation.
This table summarises the results obtained following footpad injection of the strain 17 
viruses. They have similar LD50s with less than 10 fold difference.
^ ^ D o s e
Virus
4
10 105 106 10 6 10? LD50
Strain 17
*
2/6 3/8 8/8 8/8 ND 10 5
gC negative 0/6 3/8 4/8 4/4 4/4 10 6
* number of deaths/number injected 
ND = not done
Table 4.4: Intracranial pathogenicity studies of HSV-1 strain 17 wild type 
and gC negative mutant.
This table summarises the results obtained following intrcranial inoculation of the strain 
17 viruses. They have similar LD50s with less than 10 fold difference.
^ ^ \ D o s e
V i r u s ^ ^ ^
10 1 10 2
3
10 104 LD50
17+
*
7/7 6/6 6/6 6/6
1
<10
gc- 1/6 5/6 5/7 7/7 5X101
*= no. deaths/no. injected
Figure 4.13: Percentage reactivation of HSV-1 strain 17 and its gC 
negative mutant from latently infected ganglia.
This graph shows that both viruses followed a simmilar pattern of reactivation.
Reactivation
Figure 3.14 Structure of HSV-1 gC negative mutants used in this study.
A. An expansion of the HSV-1 genome from np 87744-107022. The position of the 
BamHl, Kpnl, Nsil, Nhel and EcoRN sites are shown as are the locations of UL43 and 
UL44 which are indicated by solid boxes and run in the 5' to 3' direction.
B. The sizes of the fragments obtained from this region by digestion of HSV-1 DNA 
with BamHl.
C. The sizes obtained by BamHl digestion of the HSV-1 strain F gC negative virus, 
R6012, showing the position of the end points of the deletion. The size of the deletion is 
shown in the marked box.
D. The sizes obtained by BamHl digestion of the HSV-1 mutant viruses, SC16-AUL44-
Z and HFEM-AUL44-Z. Here the deletion in gC (as for R6012, line C) is replaced by a 
3.1Kb insert indicated by a solid box.
E. The sizes obtained bu BamHl digestion of the HSV-1 strain 17 virus with a lacZ insert 
in the Nsil site in UL43
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Figure 4.15: Profile of HSV-1 gC negative viruses.
An autoradiograph of HSV-1 DNA digested with BamHI, Southern bloted and probed 
with 32P labelled Kpnld (see figure 4.14 for example sizes of bands).
Lane 1: a Kb ladder was run to provide molecular weight markers. The sizes of the bands 
are marked on the left hand side.
Lane 2: HFEM-AUL44-Z the 6.64kb band is replaced by bands of 5.1kb (indicated by *) 
and 600bp. The 600bp band is not visible on this gel.
Lane 3: HFEM wild type virus with the predicted bands of 8.05kb, 6.64 kb, 3.86 kb and 
717bp.
Lane 4: gC negative mutant, SC16-AUL44-Z which produces the same pattern of bands 
as HFEM-AUL44-Z (Lane 2).
Lane 5: SC16 wild type virus, with the predicted bands of 8.05kb, 6.64 kb, 3.86 kb and 
717bp.
Lane 6 : gC negative lacZ expressing form of HSV-1 strain 17, where the wild type band 
of 6.64kb is replaced by bands of 3.3kb (indicated by **) and 7.3kb 
Lane 7: wild type strain 17 lacZ virus, where the wild type band of 6.64kb is replaced by 
bands of 3.3kb (indicated by **) and 7.3kb
Lane 8 : the strain 17 gC- mutant, with bands of 8.05kb, 6.64 kb, 3.86 kb and 717bp. 
Lane 10: R6012, the gC negative mutant for strain F. In this case the 6.64kb band is 
replaced by a 5.26kb band due to the deletion in UL44.
Lane 1 l:wild type strain F with bands of 8.05kb, 6.64 kb, 3.86 kb and 717bp.
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Figure 4.16: Western Blot of gC produced by HSV-1 wild type and gC 
negative strains
Western blot of extracts prepared on BHK21/C13 cells infected with various HSV-1
viruses, harvested 20 hrs post infection. The incubation temperature was 37°. Samples 
were run on a 7.5% SDS PAGE, and probed with antibodies against gC. Bands of 60K, 
55K and 52K are detected in all wild type samples.
The marker lane shows bands at 66K and 46K.
The wild type viruses all have a band at the site of gC (60K). They also have a second 
smaller band that is precursor gC (55K, 52K). In the case of strain F there are two 
precursor gC bands and there is more precursor gC than gC. This is due to differences in 
rate of progression of infection.
The gC negative mutant lanes do not show bands of gC or Precursor gC, they do 
however show a non specific band at apporoximately 40K. This band is also seen in the 
mock infected lane.
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Figure 4.17: Adsorption kinetics of HSV-1 strain SC16 and its gC 
negative mutant SC16- UL44-Z on BHK21/C13 cells.
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Figure 4.18: Adsorption kinetics of HSV-1 strain HFEM and its gC 
negative mutant HFEM - UL44-Z on BHK21/C13 cells.
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Figure 4.19: Adsorption kinetics of HSV-1 strain F and its 
mutant R6012 on BHK21/C13 cells.
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Figure 4.20: Adsorption kinetics of HSV-1 strains 17 and SC16 on 
BHK21/C13 cells.
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Figure 4.21: Adsorption kinetics of HSV-1 strains 17 and SC16- U L 4 4 -Z  
on BHK21/C13 cells.
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Figure 4.22: Adsorption kinetics of HSV-1 strains 17 and HFEM on 
BHK21/C13 cells.
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Figure 4.23: Adsorption kinetics of HSV-1 strains 17 and HFEM-AUL44- 
Z on BHK21/C13 cells.
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Figure 4.24: Adsorption kinetics of HSV-1 strains 17 and F on
BHK21/C13 cells.
BHK21/C13, 17+and F.
Figure 3.25: Adsorption kinetics of HSV-1 strain 17 and the strain F gC 
negative mutant, R6012 on BHK21/C13 cells.
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Figure 4.27: Adsorption kinetics of all HSV-1 strain 17 viruses used in 
this study on Vero cells.
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Figure 4.28: Adsorption kinetics of HSV-1 strain SC16 and its gC 
negative mutant SC16- UL44-Z on Vero cells.
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Figure 4.29: Adsorption kinetics of HSV-1 strain HFEM and its gC 
negative mutant HFEM- UL44-Z on Vero cells.
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Figure 4.30: Adsorption kinetics of HSV-1 strain F and its gC negative 
mutant R6012 on Vero cells.
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Figure 4.31: Adsorption kinetics of HSV-1 strains 17 and SC16 on Vero 
cells.
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Figure 4.32: Adsorption kinetics of HSV-1 strain 17 and the SC16 gC 
negative mutant SC16- UL44-Z on Vero cells.
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Figure 4.33: Adsorption kinetics of HSV-1 strains 17 and HFEM on Vero 
cells.
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Figure 4.34: Adsorption kinetics of HSV-1 strain 17 and the HFEM gC 
negative mutant HFEM- UL44-Z on Vero cells.
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Figure 4.35: Adsorption kinetics of HSV-1 strains 17 and F gC on Vero 
cells.
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Figure 4.36: Adsorption kinetics of HSV-1 strain 17 and the HSV strain F 
gC negative mutant R6012 on Vero cells.
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Figure 4.37: Comparison of adsorption as measured by Giemsa and p- 
galactosidase staining.
These two methods of staining were compared using HSV-1 strain 17 wild type and the 
lac Z expressing form of this virus in order to ensure that they gave similar plaque 
numbers and therefore values for adsorption.
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Figure 4.38: Adsorption kinetics of HSV-1 strain 17 lacZ and its gC 
negative lacZ expressing mutant on HeLa cells.
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Figure 4.39: Adsorption kinetics of HSV-1 strains 17 lacZ and SC16- 
AUL44-Z on HeLa cells.
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Figure 4.40: Adsorption kinetics of HSV-1 strains 17 lacZ and HFEM- 
AUL44-Z on HeLa cells.
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Figure 4.41: Adsorption kinetics of HSV-1 strain 17 lacZ and its gC 
negative lacZ expressing mutant on 3T6 cells.
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Figure 4.42: Adsorption kinetics of HSV-1 strains 17 lacZ and SC16- 
AUL44-Z on 3T6 cells.
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Figure 4.43: Adsorption kinetics of HSV-1 strains 17 lacZ and HFEM- 
AUL44-Z on 3T6 cells.
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Heparin inhibition experiments.
The graphs presented here in figures 4.44 to 4.49 show that addition of exogenous 
heparin results in inhibition of viral binding. Binding in the absence of exogenous 
heparin is considered as 100% binding and all other values are expressed as a percentage 
of this value. The gC negative viruses are generally less sensitive to the presence of 
exogenous heparin than their parental viruses.
Figure 4.44: Inhibition of adsorption of HSV-1 strain 
negative mutant by addition of exogenous heparin.
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Figure 4.45: Inhibition of adsorption of all HSV-1 strain 17 viruses used 
in this study by addition of exogenous heparin.
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Figure 4.46: Inhibition of adsorption of all HSV-1 viruses used in this 
study by addition of exogenous heparin.
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Figure 4.47: Inhibition of adsorption of HSV-1 strain SC16 and its gC 
negative mutant SC16-AUL44-Z by addition of exogenous heparin.
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Figure 4.48: Inhibition of adsorption of HSV-1 strain HFEM and its gC 
negative mutant HFEM-AUL44-Z by addition of exogenous heparin.
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Figure 4.49: Inhibition of adsorption of HSV-1 strain F and its gC 
negative mutant R6012 by addition of exogenous heparin.
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Figure 4.50: Inhibition of adsorption of all HSV-1 gC negative mutants 
used in this study by exogenous heparin.
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